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Controlled release drug delivery systems are, depending on the desired effect, generally an improvement 
over conventional drug delivery. Through material design, drugs can be delivered with temporal and spatial 
control, ideally delivering a therapeutically relevant dose for a relevant duration. Hydrogels, a network of 
cross-linked water-soluble polymers, are a common choice of material for creating such a delivery system, 
due to their general similarity to biological tissue because of their high-water content. Hydrogels can be 
used in a variety of formats for drug delivery, with options on length scales from nanometers to centimeters, 
with microparticles being a common choice. When used biologically, it is important that the polymers used 
are biocompatible. One polymer option is starch, the polymer obtained from starch granules. The work 
presented in this thesis aims to use hydrogel-like microparticles created from native starch granules through 
a simple swelling process for a controlled release drug delivery system. In working towards this goal, the 
starch granule swelling process and swelled starch itself are characterized. 
First, helium ion microscopy (HIM) was used to characterize the morphology of native corn starch. HIM is 
a relatively new method, which is similar to scanning electron microscopy, but instead of using an electron 
beam, a beam of He+ is used. HIM can create images that have high contrast, high depth-of-field, and can 
resolve features down to a few nanometers. The method has been particularly useful for nanomaterials 
research and has been used on a number of materials, such as nanoporous SiO2, cellulose nanofibrils, and 
mammalian cells. To the best of my knowledge, this is the first report of this method for imaging starch. 
The images I produced are capable of resolving features of starch not possible with scanning electron 
microscopy (SEM). With some areas of starch structure still not well understood, further characterization 
with HIM can assist with improving the understanding of starch’s structure. “Blocklets,” which are 
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theorized substructures of starch were not observed using HIM. These structures are often referred to in the 
literature, but evidence for their existence is contentious. 
Next, the process of making starch microcapsules (a term used in this thesis for swelled particles made from 
native normal corn starch granules) by manipulating physical conditions was studied. When heated in water, 
starch swells and undergoes partial gelatinization. The swelling process for normal corn starch was 
controlled with heating temperature and heating time. As a result of particle size and particle solubility 
being correlated with swelling extent, these properties were also controlled. The internal cavity present in 
native corn starch granules increased in size as the particles swelled. This size of the internal cavity was 
modulated through control of swelling extent. It was hypothesized that a microparticle with an internal 
cavity could allow for an improvement of controlled release compared to a similar microparticle without 
an internal cavity. The internal cavity of SMCs was characterized using SEM, HIM, brightfield microscopy, 
polarizing light microscopy, and confocal laser scanning microscopy. The swelling process and the 
resulting change in internal cavity size was mathematically modeled. 
To evaluate the most appropriate SMCs for use in drug delivery, the starch swelling process, differences 
between SMCs created from different starch types, and a number of properties of SMCs were studied. The 
response of pea, potato, wheat, waxy corn, and normal corn starch to various heating temperatures were 
evaluated. The morphological changes of the SMCs were characterized using SEM and brightfield 
microscopy. The effect of swelling on particle size distributions was measured and the polydispersity 
increased as expected. Normal corn starch type appeared to be best suited for use in a drug delivery system. 
With swelling power being a key measurement for characterizing SMCs, the effect of centrifugal force was 
evaluated; higher force led to lower measurements of swelling power. 
 
vii 
The digestibility of microparticles is a key factor for particles intended for oral drug delivery, and so the in 
vitro digestibility of SMCs was evaluated. Greater swelling led to higher digestibility. As a method of 
altering the rigidity of SMCs to potentially lock-in drugs, the outer shell of the SMCs was cross-linked. The 
cross-linking resulted in inhibited swelling when the SMCs were subjected to greater heating. Selective 
water uptake in SMCs was observed when SMCs were placed in a solution of bovine serum albumin (BSA), 
suggesting that SMCs are limited in the size of molecule they can carry. 
Finally, preliminary investigations into the ability of SMCs to be loaded with a drug and to subsequently 
release it were conducted. A challenge with characterizing loading of microparticles is the interstitial and 
intraparticle volume of water amongst tightly packed microparticles, the sum of which I term “drug-
accessible water.” Often the effect of this volume is ignored when determining loading capacity, but to 
properly characterize loading, this volume must be accounted for. Additionally, when characterizing 
adsorption, it is generally assumed that the hard sphere size exclusion is negligible. However, this 
assumption is not reasonable for large molecules. To improve loading characterization, these factors must 
be considered. SMCs were loaded with methylene blue (MB) and the drug-accessible-water volume was 
determined. The data was fit to a Langmuir adsorption isotherm, and adsorptions of 3.61, 2.14, and 2.06 
mg/g for native normal corn starch, SMC65, and SMC70 were observed, respectively. Due to greater 
swelling and resulting greater drug-accessible-water volumes, the opposite trend was observed for loading 
capacities, where native normal corn starch, SMC65, and SMC70 had loading capacities of 3.81, 5.11, and 
9.65 mg/g, respectively. The fraction of the drug-accessible water that is interstitial verses intraparticle was 
also estimated based on a comparison of experimental results with geometrically calculated theoretical 
swelling powers. An experimental method was used to directly calculate the interstitial volume. In addition, 
confocal laser scanning microscopy (CLSM) with the fluorescent dyes RITC-dextran and FITC-BSA as 
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model drugs, was used to visualize drug loading and to determine where drugs were loaded spatially within 
the SMCs. Drug can be found in the internal cavity of SMCs. 
In conclusion, swelled normal corn starch granules show promise for use in a drug delivery system. 
Modulation of heating temperatures and times allowed for control of the swelling extent and of the size of 
the internal cavity. The microcapsules are candidates for use in a controlled release drug delivery system. 
Further work to characterize the interaction between the microparticles and more model drugs should be 
conducted. In addition, in vitro testing in simulated intestinal and gastric fluids needs to be conducted to 
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Chapter 1: Introduction 
 Overview 
Conventional delivery of drugs, with all its upsides, has some downsides too. Often the dose needed to 
cause a therapeutic effect can have negative side effects or can even cause toxicity. Controlled release drug 
delivery systems offer one way to improve spatial and temporal control of drug release. Hydrogels are often 
the material of choice due to their high water content which is similar to biological tissue (Li & Mooney, 
2016). By forming the hydrogels into microparticles or nanoparticles, the delivery system can be 
customized and can decrease the invasiveness of the system. To be used for drug delivery, the polymers 
used to form the hydrogel must be biocompatible.  Being both inexpensive, widely available, and 
biocompatible, starch is an ideal candidate for creating a hydrogel to be used for controlled release drug 
delivery. Starch has also been used in conventional drug delivery as a natural excipient in tablets and 
capsules (Builders & Arhewoh, 2016). 
In the initial stages of our research, we characterized the internal cavity that is found in normal (as opposed 
to high-amylose or waxy) corn starch. Another term for corn starch is maize starch. When starch granules, 
the 1-100 µm diameter energy storage system of most plants (Tester et al., 2004), are heated in an excess 
of water, they swell and undergo gelatinization, the process by which the starch polymers (amylose and 
amylopectin) become fully dissociated and hydrated. Through investigating the swelling process of normal 
corn starch, we observed that the internal cavity swells in size as the particles swell. Partially swelled 
granules can be created by halting the swelling process, creating hydrogel-like microcapsules through a 
relatively simple method. Our goal was to utilize this natural microcapsule and to determine if it could be 
used to encapsulate drugs which could later be released in a controlled fashion. As the particles swell, the 
ratio between the outer wall and the internal cavity changes, potentially allowing for tunable diffusion 
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profiles of drugs through the outer wall. Unlike most other work which has created starch-based 
microparticles with a bottom-up approach where the starting materials are fully hydrated starch polymers 
(i.e. not in granular form), our approach was a top-down approach which could have the benefit of creating 
microparticles with properties not possible with a bottom-up approach. 
Despite the fact that starch is widely used in many industries and that research on starch structure has been 
ongoing since the 1930s (Badenhuizen, 1956), and the structure of starch granules is not entirely understood 
with gaps in our understanding of molecular packing and features on the nanoscale (Bertoft, 2017). Starch 
granule structure is quite complex and depends on the starch source (Pérez & Bertoft, 2010; Shujun Wang 
& Copeland, 2015). In addition, while there is a lot of research on native granules and on gelatinized starch, 
research on partially swelled starch has been minimal. Further, research on the changes of the internal 
structure of partially swelled starch is very sparse. 
The work presented in this thesis aims to create a drug delivery system using microcapsules created from 
native starch granules. In pursuit of this aim, we contribute to the field’s understanding of internal starch 
structure in native granules and in partially swelled granules. We also perform preliminary investigations 
into the ability of the swelled microcapsules for loading and releasing drugs and demonstrate proof-of-
concept for this capability. 
 Research Objectives 
The primary objectives of my research were as follows: 
• To characterize the starch swelling process to allow for the creation of starch microcapsules made 
from partially swelled starch granules 
• To probe the structure of partially swelled starch through several types of microscopy 
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• To characterize various properties of starch microcapsules which are relevant for their use in 
drug delivery 
• To evaluate the ability of starch microcapsules to encapsulate and release drugs 
 Thesis outline 
After this introductory chapter, this thesis consists of one chapter on literature review (Chapter 2), four 
chapters with experimental results (Chapters 3-6) and one concluding chapter (Chapter 7). 
Chapter 2 consists of a comprehensive literature review of recent developments in the field of starch-based 
microparticles for use in drug delivery. It covers methods for producing such microparticles and the various 
characterization methods of the microparticles and of their drug loading and release capabilities. 
Chapter 3 discusses the use of helium ion microscopy (HIM) for imaging of starch granules, a novel use 
for the relatively new microscopy method. We demonstrate its capacity for resolving features of starch on 
the order of ~10 nm and compare the images to images produced with scanning electron microscopy (SEM). 
Chapter 4 focuses on the swelling process of normal corn starch granules for producing starch 
microcapsules (SMCs). It demonstrates the ability to control the swelling extent and the soluble starch 
fraction through heating temperature and heating time. The microcapsules are characterized to understand 
their internal structure and how the internal cavity changes as a result of microparticle swelling. A 
mathematical model is produced to describe the swelling behavior which closely matches our experimental 
results. 
Chapter 5 focuses on establishing the most suitable type of swelled starch for use in a drug delivery system 
and on understanding relevant aspects of these swelled SMCs. Various starch types are evaluated, and we 
determine normal corn starch in the swelling range of 60-70 ̊ C to be most suitable. With the goal of loading 
the particles through adsorption for the purpose of controlled release of drugs, we evaluate particle size 
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distributions, swelling extent characterization, digestibility, composition changes, cross-linking effects, 
zeta potential, and selective water uptake. 
Chapter 6 contains preliminary investigations of drug loading into and release from SMCs. We use the 
model drug methylene blue to measure the adsorption capacity of the microcapsules. We demonstrate use 
of a method for quantifying drug adsorption while accounting for drug which is absorbed into the particles 
but not adsorbed. We evaluate the interaction between several model drugs and SMCs to attempt to 
characterize the interstitial volume between particles when they are tightly packed. Confocal laser scanning 
microscopy is used to observe loading of fluorescent model drugs. 
Chapter 7 concludes the thesis by providing an overview of important findings and by suggesting 
recommendations and outlook for the work.
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Chapter 2: Literature review 
 Introduction 
Controlled-release drug delivery systems (DDSs) can provide both spatial and temporal control of drug 
release, offering the potential to improve bioavailability and to reduce toxicity to unintended areas (Li & 
Mooney, 2016). Controlled release can be attained by designing particles that either (a) act as a physical 
barrier to slow diffusion, (b) use polymers that are environmentally responsive (e.g. to temperature, 
enzymes, or pH), (c) degrade over time, or (d) have a combination of the previous methods. Starch-based 
particles can be designed with these attributes in mind and are an exciting option as starch has the benefit 
of being easily accessible, inexpensive, and biocompatible. While starch may be used in formats ranging 
from nanometers to centimeters, our review focuses on starch-based microparticles (i.e. 1-1000 µm in 
diameter). 
There are many ways in which starch-based microparticles can be used for drug delivery. Most research on 
such DDSs has focused on the microparticles being used orally for the delivery of drugs to the colon or 
small intestine. By avoiding the release of drugs into the stomach and/or the small intestine, less drug is 
lost through degradation in the gastrointestinal tract. Lower loss leads to higher absorption into the 
bloodstream, allowing for increased bioavailability, which has multiple advantages. Another benefit is that 
starch-based DDSs can improve the delivery of poorly water soluble drugs (Jiang et al., 2014). In addition, 
while drugs are typically delivered to increase their concentration in the blood stream, in some cases the 
intended site of action is the colon itself; the use of starch-based particles can be helpful in these instances 
as well. For example, Ahmad et al. (2013) created a starch-based DDS with the intent of using it for 
treatment of colon cancer. Work has also been done with the intent of using starch-based DDSs for other 
purposes, such as for rapid hemorrhage control (Su et al., 2019), topical wound healing (Rehan et al., 2019), 
gastroretentive oral delivery (Lemieux et al., 2015), and intranasal administration (Mao et al., 2004). It is 
also worth noting that starch-based microparticles have been used medically without the delivery of drugs 
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for treating liver cancer through transarterial chemoembolization (TACE) (Goerg et al., 2019; Schicho et 
al., 2018) and in vaccines as an immunostimulant (Moreno-Mendieta et al., 2017, 2019; Wikingsson & 
Sjöholm, 2002). 
Starch is a polymer that is derived from plant sources. Its natural state in the plant is as a starch granule, 
which can range from 1 – 100 µm in diameter, with size highly dependent on plant type (Tester et al., 2004). 
This granule consists of two types of polysaccharides: amylose and amylopectin (Fig. 2.1). Although 
occasionally confusing, “starch” can refer to either the starch granule or the starch molecules – amylose 
and amylopectin. The composition of starch varies widely depending on the plant source. However, 
amylose typically makes up 20-30% of the granule with the remainder being amylopectin (Singh et al., 
2003a). Both amylose and amylopectin consist of repeating units of glucose monomers. Amylose is a linear 
polymer linked by a-(1-4) glycosidic bonds, while amylopectin is a branched polymer linked by linear a-
(1-4) glycosidic bonds with branch points occurring every 20-30 units with a-(1-6) glycosidic bonds (Karim 
et al., 2000). Amylopectin molecules typically have molecular weights that are 10 times that of amylose 
(Zhong et al., 2006). Starch granules also have slight amounts of protein, fatty acids, and minerals that can 
affect the properties (Rosicka-Kaczmarek et al., 2016; Zhu, 2015). Corn starch tends to be the most common 
type of starch used, likely because: a) it is the most highly researched type of starch, and thus the most 
characterized, b) it is easily available in most regions, and c) there are various strains which allow for either 




Figure 2.1: The constitutive polymers of starch: amylose and amylopectin 
Although starch is often used in its unmodified form simply as amylose and amylopectin, starch can also 
be modified to improve its properties. Examples of modified starch are carboxymethyl starch, acetylated 
starch, hydroxyethyl starch, octenyl succinyl anhydrous (OSA) starch, starch acetate, vinyl-grafted, and 
acryloyl starch. Various block co-polymers can also be created from starch, one example being starch-PEG. 
The scope of this review includes discussion of starch-based particles, which have either been evaluated 
for drug delivery capabilities or have been created with such an application in mind. These particles are 
often called many things, with ‘microparticle’ being the broadest descriptor. Some researchers have taken 
liberties with how they describe starch-based particles, however there are some general guidelines. 
‘Microcapsule’ is typically used to describe particles that have an outer shell structure and inner core 
structure; the core may either be solid or non-solid. ‘Microsphere’ is typically used to describe particles 
which are mostly spherical and homogenous throughout. ‘Microgel’ is typically used to describe particles 
which are strictly a hydrogel. In this review, we generally refer to all particles using the general term of 
microparticles. For microparticles to be considered “starch-based” at least half of the weight of the particles 
should come from starch itself. 
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The focus of this review is on microparticles where the particles are both intended for drug delivery and 
demonstrate some capability for drug release. Although some work has been done with starch-based 
microparticles for delivery of oils (Xiao et al., 2019), food ingredients (Maia et al., 2019; Nogueira et al., 
2020), nutrients (Adejoro et al., 2019), and microorganisms (Avila-Reyes et al., 2014; Muhammad et al., 
2018), such work isn’t covered in this review. Some research has also been conducted on use of starch-
based films to deliver drugs directly (Tuovinen et al., 2004) or through the use of films that contains drug-
loaded microparticles (Bie et al., 2016; Huo et al., 2016). These types of systems will also not be covered 
in this review. This review covers production methods, drug loading and release, and potential applications 
for starch-based microparticles intended for use in drug delivery. 
 Starch-based microparticles 
The first step of starch-based drug delivery is to create the microparticles. Similar to how there are many 
ways to make polymer-based microparticles, the same is true with starch-based microparticles. It is 
challenging to categorize the microparticles into types because there is some overlap with the various types. 
Common formation techniques include cross-linking, emulsification, and ionotropic gelation. Often 
multiple techniques are combined. 
Nearly all research has focused on microparticles that were created using a bottom up approach: creating 
something larger by starting with smaller components. In general, native starch granules are first broken 
down into their component molecules — amylose and amylopectin — through gelatinization. To gelatinize 
starch granules, they are heated (typically at a temperature between 40-140˚C) in a solution with an excess 
of water (typically between 0.5-20% (w/w)) for a period of time (typically 15 min to 2 hours). With an 
excess of water, higher heating temperatures and longer heating times lead to greater gelatinization. 
Gelatinization can also occur when starch granules are treated with an alkaline solution without heating 
(Ragheb et al., 1995). However, this method isn’t commonly used. The gelatinization process can be altered 
when plasticizers (Ismail et al., 2016; Lara & Salcedo, 2016; Nashed et al., 2003) or neutral salt solutions 
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(Jay‐Lin Jane, 1993) are used instead of pure water.  This solubilized starch is often the starting point for 
creating microparticles. In addition, starch can also be modified through functionalization or co-
polymerization. 
2.2.1.1 Preparation of starch-based microparticles 
To create particles from a solution of starch or a starch-based polymer, the polymer must be formed into a 
particle-like shape in some way. Methods for achieving such a shape are spray drying, emulsification, or 
dripping of the polymer into another solution to extract the solvent while leaving the polymer. In some 
cases, physical attractive forces are enough to maintain a rigid microparticle structure. In other cases, ionic 
or chemical cross-linking is used to hold the particles together or to improve their rigidity. Various methods 
are frequently combined to allow for better control in order to produce the most suitable particles for the 
intended application. A summary of recent work is provided in Table 2.1. 
2.2.2 Spray drying 
Spray drying is a process in which dry particles are produced by dispersing a liquid mixture or solution into 
a hot gas. To make starch-based microparticles for drug delivery through spray drying, typically gelatinized 
or homogenized starch and drug are added to form an aqueous slurry. When the slurry is atomized into the 
hot gas (typically air), the water evaporates, and the starch physically entraps the drug through 
intermolecular forces as the microparticle forms. Often non-starch components such as gelatin (H. Chen et 
al., 2017; Trindade & Grosso, 2000) or xanthan gum (He et al., 2016) are added to the slurry to improve 
loading capabilities or to provide stability to the loaded drugs in the microparticles. 
It is worth noting that while freeze drying has some similarities to spray drying, freeze drying by itself 
generally cannot be used to create particles as there is no mechanism in the process that can cause a 
homogenous hydrogel to separate into particles. Freeze drying is a useful process for drying already-formed 
particles, as freeze drying can minimize some of the negative effects of conventional drying. Both spray 
drying and freeze drying can be used for loading particles with drugs. 
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Palma-Rodriguez et al. (2013) used spray drying to encapsulate ascorbic acid, also known as vitamin C, 
using native rice starch, and modified (acid-treated and subsequently gelatinized) rice, maize, and potato 
starch. To form the particles, a 15% w/w mixture of starch in water with ascorbic acid (10% by weight, 
relative to starch) was spray dried at 7 mL/min with inlet and outlet temperatures of 160˚C and 110˚C, 
respectively. The particles were stored at 4˚C at low humidity. The morphology of their particles varied 
considerably. The native rice starch particles (mean diameter of 7.2 µm) resembled “popcorn” balls, which 
the authors report being held together by protein structures. As for the acid modified rice starch, the particles 
(mean diameter of 7.0 µm) had a smooth appearance, the result of fully gelatinized starch molecules 
coalescing uniformly during spray drying. The modified maize and potato starch were similarly smooth 
with mean diameters of 5.8 µm and 5.7 µm, respectively. The authors reported on the stability of the 
ascorbic acid, based on how much was retained over a period of a few weeks. They found that the native 
rice starch microcapsules had the least amount of ascorbic acid degradation, while the modified starch 
microparticles all had considerably higher degradation. However, the native rice starch microparticles had 
a lower encapsulation efficiency of 58% compared to encapsulation efficiencies ranging from 64-98% for 
the modified starch microparticles. The authors suggested a positive correlation between how much 
ascorbic acid was on the surface and the rate of degradation with storage. Similar work was subsequently 
done by Hoyos-Leyva et al. (2018) using native taro starch where they created similar “popcorn” balls 
loaded with L-ascorbic acid with a total encapsulation efficiency of 99%. The authors suggested that 
forming such microparticles from native granules is only possible with small granules of less than 10 µm 
in diameter and a sufficiently high protein content as the binding agent. They also reported an inverse 
correlation between the relative humidity and the rate of degradation of ascorbic acid. 
Liu et al. (2007) used sweet potato starch to encapsulate diclofenac sodium (DS, MW: 318 g/mol) with 
spray drying. Native starch (2, 3, or 4% w/v) and DS (1 or 2% w/v) were added together in water and heated 
at 80˚C for 2 hours to cause gelatinization of the starch. The liquid was spray dried with a feed rate of 2 
mL/min and an inlet temperature of 130˚C. Particle diameters showed dependence on the amount of starch, 
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with particles made with 2% starch having a mean diameter of 10.3 µm and particles made with 4% starch 
having a mean diameter of 13.1 µm. In all ratios used, the encapsulation efficiency was above 95%. Release 
was tested into PBS at 37˚C through a cellulose dialysis membrane with greater than 70% release of DS in 
6 hours for all particle types. The authors fit the release data to the Higuchi equation with a good fit, 
indicating that release is governed by Fickian diffusion. They did not, however, mention the molecular 
weight cut-off of the dialysis membrane or provide a control for diffusion of pure DS through the dialysis 
membrane. 
A different approach for encapsulating drugs involves spray coating a drug-containing core. The core 
contains the drug and an accessory polymer and can be made through extrusion spheronization and then 
dried. A bottom-spray fluidized-bed coater is then used to coat the microparticle cores with a starch-based 
polymer, which acts to slow the release of the encapsulated drugs. This method has been used to encapsulate 
both 5-aminoslicylic acid (J. Chen et al., 2018; Situ et al., 2014) and insulin (Situ et al., 2014, 2015). 
Another approach that involves spray drying is spray freeze-dying, whereby the liquid feed is sprayed right 
into liquid nitrogen. Rochelle and Lee (2007) created microparticles from hydroxyethyl starch using this 
method. While, the particles encapsulated and stabilized bovine liver catalase (MW: 250 kDa), the 
stabilization was poor without also using trehalose and mannitol as stabilizers. The particles were intended 
to be used as a ballistic injection method whereby the particles are accelerated to a high speed to allow for 
penetration of the epidermis. However, it appears that such a project has yet to become available on the 
market. 
2.2.3 Cross-linking 
Cross-linking is a common technique for linking together multiple polymers. When used to create 
microparticles, cross-linking imparts mechanical stability and stiffness. It can also prevent motion of the 
polymer, potentially slowing or preventing the release of any entrapped drugs within the polymer matrix. 
Typically cross-linking is used in conjunction with another method, such as emulsification, but there has 
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been considerable work creating starch-based microparticle only through cross-linking. The basic principle 
involves reacting modified starch with a cross-linker in a homogenous solution without stirring. Once the 
cross-linking takes place, the result is a large single cross-linked structure that is theoretically a single 
molecule. To arrive at the final microparticle, this single mass is broken up mechanically into microparticle-
sized pieces and then washed and dried to obtain the final particles. 
 Yuan Li et al. (2009) were the first to use such a method to create starch-based microparticles. Oxidized 
starch (DS: 30-100%) was first produced using the oxidation catalyst 2,2,6,6-tetramethyl-1-piperidinyloxy 
(TEMPO). This process oxidizes alcohol groups at the C-6 to carboxyl groups. Sodium trimetaphosphate 
(STMP) is then used to cross-link the starch at pH 10 with heating at 40˚C by reacting with alcohol groups 
on adjacent polymer chains. STMP was used in varying weight ratios between 10-40%. After the cross-
linking takes place, the gel is pushed through a nylon cloth with a 75 µm mesh size to form the 
microparticles through mechanical fragmentation. After washing with ethanol and then acetone to remove 
the water with minimal deformation to the mesh, the particles are dried. Most particles are about 10-20 µm 
in size. The authors report that properties such as charge density and cross-linking density can be controlled. 
Due to the negative charge of the particles, they make an ideal candidate for encapsulating positively 
charged functional molecules. The authors also report environment-dependent release, with high pH, high 
salt concentrations, and enzymes all being capable of triggering release. This method has been used by 
many others to create the same particles and has been researched for delivering lysozyme (MW: 14.3 kDa; 
pI: 11.35) (Yuan Li, Kadam, et al., 2012; Bao Zhang et al., 2014, 2017; Bao Zhang, Wei, et al., 2015), 
ascorbic acid (MW: 176 g/mol) (Bao Zhang, Li, et al., 2015), anthocyanins (MW: ~300 g/mol) (Z. Wang 
et al., 2013), and beta-carotene (537 g/mol) (Shanshan Wang, Chen, Shi, et al., 2015). A variation of the 
method that used glycerol diglycidyl ether (GDGE) as the cross-linker has also been researched (L. Zhao 






The most well-researched form of creating starch-based particles for use in drug delivery is through 
emulsification. Often this method is combined with either cross-linking, which improves the structural 
rigidity of microparticles and prevents or slows diffusion of encapsulated drugs, or with spray drying, which 
causes coalescence of the particles through physical interactions. When starch is used in its unmodified 
form, it encapsulates hydrophilic molecules well, and either water-in-oil (W/O) or water-in-water (W/W) 
emulsions are used to create the particles. With modifications to make the starch polymer more 
hydrophobic, oil-in-water (O/W) or oil-in-water-oil (O/W/O) emulsions can be used to encapsulate 
hydrophobic molecules. Sometimes modifications to the starch polymer result in a structure that has both 
hydrophilic and hydrophobic properties which can improve loading of some molecules. 
There are often several variables that are used to tune the properties of the microparticles. Common 
parameters that are varied in the production process include temperature, solvents, reaction time (with or 
without cross-linking), degree of substation when modified starch is used, and drug and reagent 
concentrations. Particle size is typically highly dependent on the viscosities of the two phases, on the stirring 
speed (or droplet size if dripping method is used), and on the ratio of the two phases. 
2.2.4.1 W/O emulsion 
W/O emulsions provide a useful method for organizing water-soluble polymers into spherical structures. If 
used for encapsulation of hydrophilic drugs, generally the drugs can be loaded either during or after particle 
formation. If intended for delivery of hydrophobic drugs, the particles should be formed prior to drug 
loading. Surfactants can be used to help with stabilizing the emulsion during particle formation. 
García-González et al. (2012) used a W/O emulsion method to produce microparticles. They first mixed 
native corn starch, water, canola oil, and in some formulations, glycerol monostearate, as a surfactant to 
form a W/O emulsion. Water:oil phase ratios of 1:1, 1:2, and 1:3 were used. After heating the emulsion in 
a pressure vessel at various temperature between 95˚C and 140˚C to cause gelation of the starch, the mixture 
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was slowly cooled to 45˚C with stirring. The particles were then isolated using centrifugation and soaked 
in ethanol at 4˚C for 48 hours to allow for starch retrogradation – the process of thermodynamic 
reorganization of starch polymers over time. The authors found that higher gelatinization temperatures, 
higher stirring speeds, and the use of a surfactant all led to smaller particle sizes. Specific surface areas of 
up to 112 m2/g were achieved. The particles were subsequently loaded with ketoprofen (MW: 254 g/mol) 
using a supercritical CO2 method to adsorb the drug. 
Jiang et al. (2014) used a W/O emulsion to create microparticles 20-100 µm in size. Soluble starch (type 
not specified) was added to water and homogenized with methylbenzene, chloroform, and SpanÒ 80 as the 
organic phase in a W/O ratio of 8:100. After storing the emulsion at -20˚C (time not provided), solvent 
exchange was used to convert the hydrogel to an alcogel. The authors claim that the freezing process causes 
ice-crystal formation that leaves pores when the ice is displaced by ethanol and the particles are 
subsequently dried. The drug lovastatin (MW: 405 g/mol) was loaded into the particles by soaking the 
particles in a solution of lovastatin dissolved in chloroform. The chloroform was then evaporated, allowing 
lovastatin to precipitate into and onto the particles. Release of lovastatin into PBS was tested and 
demonstrated first-order release over about 60 min. 
Baimark and Srisuwan (2013) created microparticles from a simple process, whereby solubilized starch 
was added dropwise to ethyl acetate with stirring. Since water is miscible in ethyl acetate, the water is 
extracted from the droplet and the remaining starch polymer aggregates together to form the particles (mean 
size of 34 µm). Blue dextran (MW not specified by authors, but 2,000 kDa is most common) as a model 
drug was loaded into the particles by adding it with the starch solution before the dropwise solvent 
extraction step. Drug-free particles displayed a porous internal morphology. 
The previous three methods created particles through physical interactions.  A key limitation of physical 
interaction is their low mechanical strength. By combining emulsification with cross-linking, high strength 
particles with controllable size can be created. Lemioux et al. (2015) formed mucoadhesive microparticles 
by cross-linking carboxymethyl starch (CMS) in a W/O emulsion. Carboxylation is used to convert starch 
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to an ionic hydrophilic polymer that allows for pH-controlled release of encapsulated drugs (Lemieux et 
al., 2009). The particles were created by adding CMS (DS: 0.1 – 1.5), STMP as the cross-linker, and 
furosemide (FU; MW: 331 g/mol) as the model drug together in a basic solution as the aqueous phase to 
the organic phase that consisted of cyclohexane, chloroform, and Spanâ 80. The W/O emulsion was 
allowed to react for 4 hours to cause cross-linking of the particles within the aqueous phase. The particles 
were then washed with isopropyl alcohol. The authors tested release from the particles into Hank’s balance 
salt solution (HBSS), both at pH 1.0 and 7.4. They reported low swelling of the particles at pH 1.0, the 
result of low electrostatic repulsion between the negatively charged polymers. This led to slow release of 
FU, with first order-like release over about 2 hours.  Under pH 7.4 conditions, however, FU was fully 
released within about 5 min. The authors’ intent with the particles was to use them as a gastroretentive oral 
drug delivery system. The authors also found that the particles had higher mucoadhesion to gastric mucosa 
than to intestinal mucosa. 
A similar process was used by Zhao et al. (2008) to create microparticles by use of a W/O emulsion with 
gelatinized starch as the aqueous phase, and with cyclohexane, chloroform, SpanÒ 60, and TweenÒ 60 as 
the organic phase. N,N’-methylene bis-acrylamide (MBA) was used to cross-link the starch at 50˚C for 2h. 
Particles had a mean diameter of 18.2 µm. After washing, adsorption isotherms were created with 
methylene blue (MW: 320 g/mol) at various temperatures. It was observed that cooler temperatures 
corresponded to higher adsorption, with adsorption at 25˚C resulting in a saturation adsorption capacity of 
0.1064 mmol/g of particles (equivalent to 34 mg/g). Pereira et al. (2013)  also used MBA to cross-link 
vinyl-grafted starch by creating W/O emulsion and allowed cross-linking to take place for 30 min. The 
particles had an average particle size between 400-500 µm and were loaded with curcumin (MW: 368 
g/mol) through soaking to a total loading capacity of 82 mg/g. 
After first developing a simple method to create starch microparticles with only cross-linking, as described 
in Section 2.3.2, Li et al. (Yuan Li, Kleijn, et al., 2011; Yuan Li, Norde, et al., 2012; Yuan Li, Zhang, et al., 
2011) created a similar method where spherical particles were made using a W/O emulsion, but then were 
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cross-linked with STMP to increase stiffness of the particles. Oxidized starch and STMP, as cross-linker, 
were added together in a basic solution and then emulsified with an excess of hexane and SpanÒ 80. By 
immediately filtering the emulsion through a 10 µm membrane 10 times, a homogenous size distribution 
was obtained. The emulsion was heated at 40˚C for 40 min to allow for completion of cross-linking. Lastly, 
particles were washed with methanol and then stored in water. The particles demonstrated high loading of 
lysozyme (MW: 14.3 kDa) through adsorption of up to ~3 g/g. More recently, D. Li et al. (2020) used the 
same process to form microparticles, but then subsequently loaded the microparticles with nanoparticles 
through electrostatic interactions, where the nanoparticles had a positive charge attracting them to the 
negatively charged oxidized starch in the microparticle. The nanoparticles were made from amphiphilic 
lysozyme (made through partial enzymolysis at Glu and Asp sites) and loaded with quercetin (MW: 302 
g/mol). 
A variation of the W/O emulsion was used by Fang et al. (2008), where rather than emulsifying both the 
oil and aqueous phases together as is common, they dripped the aqueous phase into the oil phase. The 
aqueous phase consisted of a basic solution with solubilized starch and STMP. When dripped into the oleic 
phase of liquid paraffin, SpanÒ 80, and Tween 80Ò at 50˚C, microparticles formed and were hardened 
through cross-linking by STMP for 5h. After washing the particles with organic solvents and a saline 
solution, the particles were vacuum dried. The dried particles had a mean d4,3 diameter of ~19 µm. A soaking 
method was used to load the particles with methylene blue to a maximum loading capacity of 330 mg/g; 
loading was dependent on temperature, drug concentration, media type, and time.  
2.2.4.2 W/W emulsion 
This method takes advantage of two aqueous solutions with vastly different viscosities to create an 
emulsion. 
Wöhl-Bruhn et al. (2012) used UV cross-linking in a W/W emulsion to create microparticles from 
hydroxyethyl starch (HES) grafted with polyethylene glycol methacrylate (P(EG)-MA). The polymer, 
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HES-P(EG)nMA, with n = 6 or 10, had degrees of substitution between 0.3 – 1.2.  HES-P(EG)nMA (2% 
w/w), the cross-linking initiator (IrgacureÒ2959, 0.1% w/w), and a model drug (70 kDa FITC-dextran or 
FITC-IgG) were added together to form the first aqueous phase (W1). A 30 wt.% solution of 12,860 g/mol 
PEG was used as the second aqueous phase (W2). Both phases were mixed with a vortex mixer for 1 min 
to form the W/W emulsion; various W1:W2 ratios were used for different formulations. Cross-linking was 
done with 366 nm light for 30 min and then particles were washed with DI water and freeze-dried. Mean 
diameter ranged from about 5 to 40 µm and was dependent on polymer solution concentration and the 
PEG:polymer ratio in the W/W emulsion. Cryo-SEM revealed a highly porous interior (Fig. 2.5). Controlled 
release (which appears first-order) into PBS of FITC-dextran with the HES-P(EG)10MA particles showed 
faster release (65% release at 30 days) than the HES-P(EG)6MA particles (45% release at 30 days). 
However, release by 400 days was about 90% for both. When a-amylase was added to the release media, 
release occurred faster. 
Elfstrand et al. (2009) had previously used a similar method. The W1 phase contained ~22 wt.% starch and 
0.95 wt.% protein (either insulin or bovine serum albumin [BSA]) and the W2 phase was a 38 wt.% solution 
of 20,000 g/mol PEG. Both phases were mixed together and then incubated at 6˚C for times between 5-48 
hours, followed by incubation at 37˚C for times between 5-24 hours. Unlike the other work by Wöhl-Bruhn 
et al. (2012), no cross-linker was used, and the particles were held together with physical interactions only. 
2.2.4.3 O/W emulsion 
Panyoyai et al. (2017) encapsulated tocopheryl acetate (MW: 473 g/mol), also known as vitamin E acetate, 
into microcapsules made from modified waxy maize starch using spray drying. The starch was modified 
by grafting octenyl succinate, a molecule with a polar 8-carbon tail, at just below 3% content, to induce 
some hydrophobicity to the starch. Since tocopheryl acetate is a relatively viscous oil and insoluble in water, 
it was dissolved in ethanol and then homogenized with the modified starch in water to form an O/W 
emulsion with a starch:tocopheryl acetate weight ratio of 19:1. This emulsion was spray dried with a feed 
 
18 
rate of 7.5 mL/min with inlet and outlet temperatures of 120˚C and 75˚C, respectively. The particles were 
then stored at -30˚C. The authors reported an encapsulation efficiency of 90% and studied the release into 
ethanol at temperatures ranging from -30 to 70˚C. They found the release profile reached equilibrium in 
about 1 min with a total release of only about 10% of the encapsulated tocopheryl acetate. They also found 
a strong positive correlation between release temperature and release extent. 
Deng et al. (2014) used octenyl succinate anhydride (OSA) starch to create spray dried microparticles with 
encapsulated b-carotene (MW: 537 g/mol), a hydrophobic molecule that is a precursor to vitamin A. The 
OSA starch used had a DS of 1.9% (C. Li et al., 2013). The authors compared OSA starch to soy protein 
isolate (SPI) as encapsulating materials, and they used various ratios of OSA starch, SPI, and b-carotene 
(with soy oil as carrier). After homogenization of the feed components to create an O/W emulsion (with 
total solid contents between 10-20%), the emulsion was spray dried with a feed rate of 10mL/min with inlet 
and outlet temperatures of 160˚C and 85˚C, respectively. The particles were stored in a desiccator at 4˚C 
until further use. The authors found that using a 1:1 blend of OSA starch:SPI resulted in the highest 
encapsulation efficiency, while using only OSA starch resulted in the lowest.  Stability was also studied 
with various temperatures, humidities, with/without sunlight, and with different storages times. While much 
of the results show no clear trends, OSA starch-only microparticles seemed to have the best b-carotene 
retention with storage at 60˚C. They also found little difference in b-carotene retention regardless of 
whether particles were exposed to sunlight. 
He et al. (2016) similarly used OSA starch (DS: 0.16) to encapsulate conjugated linoleic acid (CLA), a type 
of fatty acid. The authors used both OSA starch only and mixtures of OSA starch and xanthan gum in 60:1, 
80:1, and 100:1 w/w ratios. Each suspension was homogenized with 25% w/w CLA to form an O/W 
emulsion that was used as the feed for spray drying. Spray drying was done with inlet and outlet air 
temperatures of 160 and 75˚C, respectively. The authors reported particle sizes of 5-6 µm and found that 
the addition of xanthan gum provided a protective effect from oxidation for the CLA. They also reported 
the addition of xanthan gum conferred resistance to acid hydrolysis and enzymatic degradation, resulting 
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in the 60:1 ratio microparticles having ~3% release of CLA in simulated stomach conditions compared to 
~6% release with particles made with OSA starch only. Similarly, when comparing release into simulated 
intestinal conditions, they observed ~10% release for the 60:1 ratio particles compared to ~50% release 
from the particles made with OSA starch only. 
Okunlola et al. (2017) acetylated yam starch to introduce hydrophobicity that was then used to encapsulate 
a hydrophobic drug using a O/W emulsion. Repaglinide (MW: 453 g/mol) as the model drug and the 
acetylated starch (DS: ~2.6) in 1:5, 1:8, and 1:10 w/w ratios were added to chloroform and mixed. A thin 
stream of this solution was added to a 0.5% w/v aqueous solution of sodium carboxylmethylcellulose with 
stirring, causing particles to form. The particle sizes were highly dependent on the drug:polymer ratio, with 
higher amounts of drug resulting in smaller particles. The authors reported encapsulation efficiencies 
between 75-93% and extended release over 12 hours. 
Balmayor and colleagues (Balmayor, Feichtinger, et al., 2009; Balmayor, Tuzlakoglu, et al., 2009) used a 
method to encapsulate hydrophobic molecules using a blend of starch and poly-e-caprolactone (PCL) to 
increase the hydrophobicity. The blend of polymers composed the oleic phase for formation using an O/W 
emulsion with solvent evaporation. However, the particles were not strictly “starch-based,” as they used a 
30:70 weight ratio of starch:PCL to create the particles. 
2.2.4.4 O/W/O emulsion 
One final emulsion method is to create a double emulsion where starch is used as the shell material to 
encapsulate a hydrophobic drug in an inner oleic phase. The double emulsion allows for the hydrophilic 
starch-based phase to form into particles, while still encapsulating a hydrophobic molecule. 
Similar to the O/W emulsion and cross-linking methods previously described where TEMPO-oxidized 
starch is used to create microparticles, S. Wang et al. (2015) created microspheres using an O/W/O method. 
Oxidized starch (DS: 0.9) was created through TEMPO-mediated oxidation. A double emulsion process 
was used to obtain an Oi/W/Oo emulsion with the inner oil phase (Oi) consisting of b-carotene in corn oil, 
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the aqueous phase (W) consisting of oxidized starch (primarily), whey protein isolate, and Fe2+ ions, and 
the outer oil phase (Oo) consisting of paraffin oil with Spanâ 80. After the double emulsion was created, 
oxygen gas was pumped into the solution with stirring, to oxidize the Fe2+ into Fe3+ in order to induce cross-
linking between the carboxyl groups. Particles were washed with hexane and methanol, and then 
resuspended in pH 3 HCl solution where they had a mean diameter of 39 µm. The authors reported that the 
particles were stable at acidic stomach conditions (pH<2), but that the particles were disrupted in intestinal 
conditions (pH 7) to release the b-carotene. 
Ahmad et al. encapsulated the hydrophobic model drugs metronidazole (2012), 5-fluorouracil (2012), and 
irinotecan hydrochloride (2013) with an O/W/O emulsion. The Oi phase consisted of the drug and 
magnesium stearate in methylene chloride, and the W phase consisted of starch and Tweenâ 80 in water. 
After homogenizing these two phases into an O/W emulsion, this emulsion was added dropwise into liquid 
paraffin containing 1.5% v/v Spanâ 80 as the Oo phase. The particles were heated at 40˚C to promote 
extraction of water. After separating the particles with centrifugation, the particles were washed with 
hexane. Other than testing the effect of varying starch:drug ratios, where generally a higher starch content 
led to larger particles, the authors did not test the effect of other variables. As a result, it is hard to draw any 
conclusions about the effect of stirring speeds, reaction times, or other ratios. The authors conducted in vivo 
studies on rats for each drug, and in each they observed selective release into the colon, which the authors 
attribute to mucoadhesion and microbial degradation in the colon. 
2.2.5 Ionotropic gelation and polyelectrolyte complexation 
Ionotropic gelation, also called ionic cross-linking, is a process which uses polyelectrolytes (polymers with 
repeating units which carry a charge) to form ionic cross-links in the presence of counter ions to create a 
hydrogel. Nanoparticles, microparticles, and millimetre-sized particles can all be created using this process. 
Polyelectrolyte complexation is a slightly different process with a similar result: instead of counter ions, a 
polyelectrolyte polymer with opposite charge is used. Typically, a small gauge needle is used to drip one 
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solution into another, with each drop from the needle forming one particle. Historically, alginate has been 
the main polyelectrolyte used to create such hydrogels (Daly et al., 2020; J. Li & Mooney, 2016), but 
recently work has be done with incorporating modified starch to improve the properties of the hydrogels. 
Blemur et al. (2016) created microspheres using ionotropic gelation with carboxymethyl starch (CMS) 
made from high amylose corn starch and alginate (the salt of alginic acid) for encapsulation of diamine 
oxidase (DAO, MW: ~184 kDa for dimer). A ~2% solution containing CMS (DS: 0.2), sodium alginate, 
and DAO in roughly a 19:4:3 wt. ratio was added from a height of 4 cm with a 26-gauge needle (inner 
diameter 0.26 mm) into a 10% CaCl2 solution under stirring. Both CMS and alginate have a negative charge, 
so when added to a solution with the bivalent ion Ca2+, ionotropic gelation occurs, and a microsphere is 
formed. The authors report encapsulation efficiency of about 90%, with enzyme activity of about 50% after 
vacuum drying. They also evaluated the stability of the enzyme in simulated intestinal fluid; they reported 
that although enzyme activity in the microspheres was lower compared to the free enzyme control for the 
first 12 hours, for the following 12 hours, the activity was maintained at about 60% while the free enzyme 
activity decreased to close to zero. 
Rehan et al. (2019) also used ionotropic gelation to create microcapsules from starch and alginate. Their 
intent was to create an antioxidant, antimicrobial, and wound-healing cotton gauze by incorporating 
bioactive microcapsules. They created a solution with 2% sodium alginate and 4% starch, along with guava 
leaf powder extract. After soaking gauze in the solution for 15 min, the gauze was soaked in a solution with 
0.05M CaCl2 to induce cross-linking, which created microcapsules. The leaf extract is a combination of 
bioactive compounds – primarily phenols, flavonoids, and essential oils.  The authors report antimicrobial, 
antioxidant, UV protection, and wound healing properties. The wound healing studies were done on rats 
with induced wounds. 
Quadrado and Fajardo (2020) created BSA-loaded microparticles through polyelectrolyte complexation 
using carboxymethyl starch (CMS) made from rice starch and chitosan. Chitosan is a cationic polymer and 
is thus able to complex with the anionic CMS. A 3% (w/v) solution of chitosan and BSA at pH 5 was added 
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dropwise from a height of 1 cm into a 4% (w/v) solution of CMS (DS: 0.5) at pH 8.5 to form the 
microparticles. The CMS solution also contained 0.1% w/v sodium tripolyphosphate (STPP), which is a 
cross-linker, and the authors did not include a control, so it is not possible to isolate the difference between 
the effect of polyelectrolyte complexation and the effect of the STPP. Particles were about 1 mm in diameter 
and had a BSA encapsulation efficiency of 67%. Release into SGF (pH 1.2) and SIF (pH 6.8) was tested, 
and the authors reported pH dependent release, with slightly faster release into SGF. However, they 
completed the release study with dialysis membrane with a molecular weight cut-off (MWCO) of 12,000 
Da, and BSA has a molecular weight of ~66,000 Da, calling their results into question. 
2.2.6 Other methods 
Su et al. (2019) created microspheres from corn starch through cross-linking with epichlorohydrin followed 
by enzymolysis. Their intent was to use the microspheres as a hemostatic agent for control of blood loss. It 
appears the particles might have been partially gelatinized in conjunction with the cross-linking process, as 
a result of heating at 50˚C in a pH 13 solution, based on their appearance. This process is unique in that it 
is a top-down approach for making the particles. As such, the particles retain some of the original form of 
the native granules, as confirmed by the authors using FTIR spectroscopy and XRD. Large pores (~1 µm 
in diameter) were created by treating the particles with glucoamylase and a-amylase for 6 h at 50˚C. After 
loading the particles with tranexamic acid (MW: 157 g/mol), a fibrinolytic agent, through freeze drying, 
the particles were able to effectively induce blood clotting to prevent blood loss in vivo on rabbits with ear 
artery and liver injuries. In addition, the particles induced clotting faster, and with less blood loss, than a 
product currently on the market (Aristaâ). 
In another unique method, Luo et al. (2019) created microparticles through self-assembly of short chain 
glucans, which were derived from waxy maize starch. The short chain glucans were created by debranching 
gelatinized starch with pullulanase at 37˚C for times between 1 – 7 days. After centrifuging the treated 
starch, the supernatant was added to a solution with chitosan and incubated at 4˚C, inducing self-assembly 
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through recrystallization of the short chain glucans. Chitosan was also used as a steric stabilizer to minimize 
self-aggregation of the short chain glucan clusters. The use of chitosan resulted in a much more highly 
monodisperse distribution and imparted a positive zeta potential to the particles. The particles had mean 
sizes between 0.23 - 5.2 µm that were controllable based on the length of debranching time and pullulanase 
concentration. The authors loaded the particles through soaking in drug solutions. Due to their positive 
charge, the microparticles adsorbed Evans blue (MW: 961 g/mol) and Brilliant blue (MW: 749 g/mol), 
which are both negatively charged, to high loading capacities of 223 mg/g and 206 mg/g, respectively. An 
in vitro release test into SGF followed by SIF demonstrated selective release into SIF only. 
 Characterization of starch-based microparticles 
2.3.1 Size and size distribution 
An important variable for any particle-based controlled DDS is particle size. The size differences between 
nanoparticles, microparticles, and macroscopic particles determine how the particles can be used. For 
example, particles which are intended for intravenous injection need to be between 10-100 nm in diameter 
(J. Li & Mooney, 2016), excluding use of microparticles. Where microparticles lie on the 1-1000 µm range 
generally has little effect on how they can be used, but their size can affect rate of drug release (W. Chen 
et al., 2017; Dash et al., 2010). In addition, size distribution can play an important role in how uniformly 
release is controlled. A wide size distribution could mean a significant difference in how drug is released 
the largest particles to the smallest, depending on the release mechanism. Typically, diameter is reported 
for particle sizes. However, often only the ambiguous term “size” is used; we suggest authors clearly state 
what they are reporting to minimize any possible confusion. 
Laser light scattering is a common method of determining sizes and size distributions of microparticles. 
While there are different specific techniques and configurations with how light scattering is used to 
determine particles sizes, the general method can determine sizes between tens of nanometers and up to a 
few millimeters. While typically particles are imaged while wet in water (Maaran et al., 2014), ethanol 
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(García-González et al., 2012), or isopropanol (Bordenave et al., 2014; Sasaki & Matsuki, 1998), dry 
imaging is also possible, depending on the method used. One limitation is that the method assumes 
homogeneity and sphericity of the particles (Dhital et al., 2010). Another limitation of light scattering is 
that it provides no information on the morphology of the particle. With some assumptions, it is possible to 
use light scattering results to calculate the specific surface area of the particles (Maaran et al., 2014). 
Coulter counters, capable of determining diameters a little beyond the micron range, may also be used to 
determine sizes of starch-based particles. The device takes advantage of the Coulter principle: when a 
particle in an electrolytic solution passes through orifice, concurrent with an electric current across the 
orifice, the impedance changes proportionally to the volume of the particle. The orifice must be correctly 
sized depending on the size range of the particles. The method is limited to particles in solution that have 
low conductivity. Indeed, Tester and Morrison (1990) discovered that with moderate swelling of starch 
granules, a Coulter counter was not able to correctly determine swelling extent, due to the granules 
becoming conductive. This method also has the advantage of being able to count the number of particles in 
solution.  
Scanning electron microscopy, while typically used to observe morphology, can also be used to determine 
particle dimensions. This method is somewhat laborious, as the images must first be taken and then analyzed 
manually, or with software to determine dimensions (Farrag, Sabando, et al., 2018; Lecorre et al., 2012; 
Rehan et al., 2019). Similarly, confocal laser scanning microscopy (M Schirmer et al., 2013), optical 
microscopy (Lemieux et al., 2015), and helium ion microscopy (Wulff, Aucoin, et al., 2020) can be used in 
the same way. 
2.3.2 Swelling 
When drug release is controlled by swelling extent, characterizing this extent is important. Swelling ratio 
(Kowalski & Ptaszek, 2016), hydration capacity (Kim & Huber, 2013), and swelling power (Bordenave et 
al., 2014) are all simple methods that use the weight ratio of the wet swelled particles to the dry particles. 
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Unfortunately, there is not a standard method, and some researchers have come up with their own 
definitions. We would suggest the use of swelling power as it both intuitive and the simplest. Similarly, 
swelling factor uses a volume ratio of particles, but if used as initially described by Tester and Morrison 
(1990), the particles must not be permeable to or adsorb blue dextran (2,000 kDa). One advantage of this 
method is that the interstitial volume between particles is not a factor in the result, unlike with the weight-
based methods. Swelling kinetics can also be determined by measuring swelling extent as a function of time 
(Wulff, Chan, et al., 2020 [Chapter 4 in this thesis]). Often swelling analysis is done at various temperatures 
(Fundueanu et al., 2010) or in various media with different ion concentrations (Yuan Li et al., 2009) or pHs 
(de Oliveira Cardoso et al., 2020; Yuan Li et al., 2009). 
While less quantitative, starch microparticles have also been observed with optical microscopy during 
swelling to visually observe how they change (Wojtasz et al., 2016). 
2.3.3 Shape, morphology, and internal structure 
Scanning electron microscopy (SEM) is typically the method used for determining particle shape and 
morphology for starch-based particles. It is quick and creates high-resolution images. Since starch is a poor 
conductor, typically starch is sputter coated with gold between 10-50 nm in thickness (He et al., 2016; 
Nayak et al., 2018; Phromsopha & Baimark, 2014), however platinum (Desam et al., 2018) or iridium 
(Farrag, Sabando, et al., 2018) have also been used. SEM can resolve features of starch down to high tens 
of nanometers. Helium ion microscopy (HIM), a relatively new method that instead uses a scanning helium 
ion bean, has also been used to observe starch granule features down to low tens of nanometers (Wulff, 
Aucoin, et al., 2020) and could be useful for characterization of starch-based microparticles. With either 
method, particles are often sectioned or cracked open to observe their interior. A limitation of these methods 
is that the particles need to be dry. Transmission electron microscopy (TEM), while less commonly used 
compared to SEM, has also been used to image starch microparticles (Östh et al., 2003; Xu et al., 2018). 
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Confocal laser scanning microscopy (CLSM) is a particularly useful technique for observing the interior of 
microparticles intended for use in drug delivery. Particles can be loaded with fluorescent probes in the same 
way that drugs would be loaded and then imaged with CLSM. Due to the nature of CLSM, it is possible to 
see exactly where the probes are within the microparticle at a specific Z-plane. By combining a Z-stack of 
XY-plane images, a 3D image of the probes within the particle can be created. Any fluorescence molecule 
may be used, and fluorescein-based probes (e.g. FITC, FITC-dextran or FITC-BSA) are most commonly 
used (Bie et al., 2016; J. Chen et al., 2018; Östh et al., 2003), but starch microparticles have also been 
imaged using b-carotene (Shanshan Wang, Chen, Liang, et al., 2015), Nile Red and Blue (Yusoff & Murray, 
2011), RITC-dextran (Wulff, Chan, et al., 2020) and Coumarin 6 (Sun et al., 2018; Xu et al., 2018). CLSM 
is capable of resolving features in the low hundreds of nanometers. 
2.3.4 Thermal analysis 
Thermal analysis techniques can provide insight into the molecular arrangement within the starch-based 
microparticles. Differential scanning calorimetry measures the amount of heat required to increase the 
temperature of samples and gives an indication of the degree of crystallinity, and the nature of that 
crystallinity. While native starch shows very distinct endothermic peaks from the melting of crystallites 
(Jenkins & Donald, 1998; Shujun Wang et al., 2016), generally starch-based microparticles are quite 
amorphous and show a less clear peak or no peak at all (Kittipongpatana, 2013; Lemieux et al., 2015). The 
method can also provide insight into the interaction between the microparticle and loaded drug (de Oliveira 
Cardoso et al., 2020) or into the stability of the loaded drug (Okunlola et al., 2017). Thermal gravimetric 
analysis (TGA) has also been used to characterize starch-based microparticles intended for drug delivery, 
providing insight into their thermal stability (Farrag, Ide, et al., 2018; Peng et al., 2011). The relevance of 






Spectroscopy, while not frequently used in this particular area of research, can be a useful tool for evaluating 
the presence or absence of chemical groups in starch-based microparticles. X-ray diffraction (XRD) has 
been used to confirm drug loading (Nayak et al., 2018), absence of cross-linking agent (B. Li et al., 2009), 
and structural properties of microparticles (Farrag, Sabando, et al., 2018). Similarly, Fourier transform 
infrared spectroscopy (FTIR) can be used to study the interaction between loaded drug and microparticle 
(Desai, 2007; Hoyos-Leyva et al., 2018; Nayak et al., 2018; Panyoyai et al., 2017) or to evaluate 
modifications to the particles (B. Li et al., 2009; Momeni & Mohammadi, 2009; Okunlola et al., 2017; Bao 
Zhang, Wei, et al., 2015). Nuclear magnetic resonance (NMR), while rarely used to evaluate starch-based 




Table 2.1: Summary of work in literature on starch-based microparticles for drug delivery 
Particle type/name Particle fabrication 
method 






























Key findings References 
CMS microspheres W/O emulsion with cross-
linking 
Carboxymethyl starch None ~90 Furosemide Water soluble 




During 50 mg/g 50% Into HBSS at 
pH 1 and 7.4 
pH 1: 5-25 
min. pH 
7.4: <2 min 
pH 1: 15-60 
min. pH 
7.4: ~2 min 
Gastroretentive 
delivery 
Not done High swelling at pH 7.4 leads to 
rapid release of drug. 
(Lemieux et al., 2015) 
Starch microspheres Cross-linking of native 
starch with subsequent 
enzyme treatment 








The drug-loaded particles where 
able to better induce blood 
clotting on wounds compared to 
particles without drug and on 
par with a comparable product 
available on the market 
(Arista®). 




debranched short chain 
glucans and chitosan 
Short chain glucans 
from waxy maize 
starch 
Chitosan 0.2-5 Rhodamine, Brilliant 
Blue, Evans Blue 
Water soluble Soaking of particles 
in drug solutions 
After - 
adsorption 
Up to 223 
mg/g 












Not done Although the authors attempted 
to load both negatively and 
positively charged molecules, 
only the negatively charged 
molecules were successfully 
loaded, which they attributed to 
the loading mechanism 
primarily being electrostatic 
interaction with the positively 
charged chitosan. 
(Luo et al., 2019) 
Microgel particles Large scale cross-linking 
and subsequent 
grinding/sieving 
Carboxymethyl starch beta-cyclodextrin 10-25 Ascorbic acid Water soluble Soaking of particles 
















Not done Higher amounts of beta-
cyclodextrin allowed for higher 
loading and higher 
encapsulation efficiency of 
ascorbic acid. 


























Not done Loading capacity was 
dependent on the degree of 
oxidation of starch, particle 
cross-linking extent, and ionic 
strength and pH of anthocyanin 
solution. 
(Z. Wang et al., 2013) 
Cross-linked anionic 
microspheres 
W/O emulsion with cross-
linking 
"water soluble starch" None ~19 Methylene blue Water soluble Soaking of particles 




18-330 mg/g 7-84% Into saline 
solution 
~2 hours ~15 hours Not stated Not done Drug loading was higher with 
longer soaking times and higher 
drug concentrations and was 
maximal at room temperature 
and with a NaCl solution. 




Large scale cross-linking, 
grinding/sieving, and 
adsorption of additional 
polymer 
Carboxymethyl starch Chitosan ~20 Lysozyme Water soluble Soaking of particles 
in lysozyme solution 
After - 
adsorption 












Not done Loading capacity was 
dependent on the degree of 
substitution of starch and ionic 
strength and pH of lysozyme 
solution. Coating the microgel 
particles with through 
electrostatic interactions with 
CMS and chitosan slowed the 
release of lysozyme.  
(Bao Zhang et al., 
2014, 2017; Bao 









None 10-20 Lysozyme Water soluble Soaking of particles 
in lysozyme solution 
After - 
adsorption 
Up to 5 g/g Not provided Into citric acid-
PBS 
~30 min ~2 hours Not stated Not done Loading capacity was 
dependent on the degree of 
oxidation of starch, particle 
cross-linking extent, and ionic 
strength and pH of lysozyme 
solution, and release was highly 
dependent on ionic strength and 
pH of release solution. 
(Yuan Li et al., 2009; 
Yuan Li, Kadam, et 








None 10-20 Lysozyme Water soluble Soaking of particles 
in lysozyme solution 
After - 
adsorption 
3 g/g Not provided Not done - - Not stated Not done Higher loading with lysozyme 
occurred at low pH and low 
ionic strength 
(Yuan Li, Kleijn, et 
al., 2011; Yuan Li, 
Norde, et al., 2012; 







Carboxymethyl starch Chitosan 1230 Bovine serum 
albumin 














Not done Release into SIF was slightly 
slower than release into SGF, 
but the total amount released 
was nearly the same. 






Spray drying Taro starch granules None 20.8 Ascorbic acid Water soluble Spray drying During 99 mg/g 99% Not done - - Improved drug 
stability 
Not done Particles were able to protect 
against ascorbic degradation at 
high temperature and humidity. 





Ionotropic gelation Carboxymethyl starch Alginate ~600-
800 
Diamine oxidase Water soluble Physical entrapment 
through ionotropic 
gelation 
During Not provided 82-95% Not done - - Intestine-targeted 
release 
Not done Encapsulation of the enzyme 
maintained high activity 
compared to non-encapsulated 
enzyme in SIF after 24 hours. 
(L. Zhao et al., 2015) 
Film-coated 
microparticles 





None ~500 Insulin Water soluble Spray coating of 
drug 





The insulin-loaded particles 
were able to reduce plasma 
glucose concentrations in 
diabetic rats at an oral dose of 
50 IU/kg, similar to the 
response when insulin was 
injected subcutaneously at a 
dose of 35 IU/kg. 





W/W emulsion with 
cross-linking 
Hydroxyethyl starch 
(grafted with MA or 
PEG-MA) 
None ~8-40 FITC-dextran and 
FITC-IgG 
Water soluble Emulsification During Up to 14.5 
mg/g 
Up to 99% Into phosphate 
buffer and into 
PBS with alpha-
amylase 
~20 days ~100 days Not stated Not done The release rate was tunable 
based on which polymers were 
grafted onto hydroxyethyl 
starch. 
(Wöhl-Bruhn et al., 
2012) 
Starch microspheres W/W emulsion and 
subsequent freeze drying 
Mechanically treated 
and acid hydrolyzed 
waxy maize starch 
None ~100 Insulin and BSA Water soluble Emulsification and 
freeze drying 
During Insulin: Up to 
21.2 mg/g. 
BSA: Up to 
51.3 mg/g 
Insulin: Up to 
49%. BSA: Up to 
126% 
Into PBS with 
amylase 
~10 min ~30 min Sustained release 
- oral 
Not done BSA was more easily loaded 
into the particles. 
Recrystallization was a factor in 
particle formation. Protein 
release in the presence of 
amylase was faster. 
(Elfstrand et al., 2009) 
Polysaccharide-
based microparticles 
W/O emulsion with 
solvent diffusion 
Potato starch None 32 Blue dextran Water soluble Emulsification During 89.5 mg/g 89.5% Not done - - Not stated Not done When the same production was 
used to create particles from 
starch, chitosan, and alginate, 
the main effect was different 
particle sizes which the authors 
attribute to differences in 
viscosities. 




W/O emulsion with 
solvent exchange 
"Soluble starch" None 20-100 Lovastatin Poorly water 
soluble 
Vacuum drying After 140-390 mg/g 39-68% Into water at 
37˚C with pH 7 




Unlike most other research 
where particles are utilized to 
slow release of drug, this work 
demonstrated the ability of 
microparticles to accelerate 
release of poorly soluble 
Lovastatin. 
(Jiang et al., 2014) 
Starch-based 
microspheres 




None 400-500 Curcumin Poorly water 
soluble 
Soaking of particles 
in curcumin solution 










Not done High toxicity against tumor cell 
lines compared to control was 
observed. 
(Pereira et al., 2013) 
Microspheres O/W emulsion with 
solvent evaporation 
Acetylated starch None 30-350 Repaglinide Poorly water 
soluble 
Emulsification During Not provided 75-93% Into PBS ~5 hours ~10 hours Sustained release 
- oral 
Not done Higher porosity lead to faster 
drug release. They report that 
the release mechanism was a 
combination of erosion and 
diffusion. 
(Okunlola et al., 2017) 
Mucoadhesive 
microparticles 
O/W/O emulsion with 
solvent evaporation 
Rice starch None 210-367 5-fluorouracil Poorly water 
soluble 
Emulsification During Not provided 90-93% Into goat caecal 
content 
~7 hours ~18 hours Colon-targeted 
release 
With rats In vivo studies indicated 
selective release into the colon 
with minor release occurring in 
the stomach and small intestine. 
(Ahmad, Akhter, 








100-150 Bone morphogenic 




Emulsification During Not provided 25% for BMP2 Into PBS ~12 hours ~5 days Sustained release 
- injectable 
Not done The use of SPCL allow for 
encapsulation and release of 
osteogenic hydrophobic drugs 
with a minor effect on cell 
viability of unloaded 
microparticles. 
(Balmayor, 









6-914 Dexamethasone Poorly water 
soluble 
Emulsification During Not provided 75-94% Into PBS ~30 hours ~23 days Sustained release 
- tissue 
engineering 
Not done Polymer concentration and 
stirring rates had significant 
effects on particle sizes and 
morphologies. 
(Balmayor, 




W/O emulsion and starch 
retrogradation 
Corn starch None 212-
1226 




After 1.1 mg/m^2 0.16 Not done - - Not stated Not done Faster stirring speeds and the 






























With rats Loading takes advantage of the 
charge difference between 
lysozyme and oxidized starch. 
Release is highly medium 
dependent allowing for majority 
of release into SIF. Higher 
cross-linking leads to lower 
drug loading. Drug loaded into 
(D. Li et al., 2020) 
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particles showed higher 
retention in GI tract vs. control. 
Oxidized starch 
microgels 

























Not done The degree of oxidation, the 
ratio of cross-linker to starch, 
the ionic strength, and the pH 
all affected loading capacity of 
the particles. Low release in 
SGF and high release in SIF 
was achieved. 
(Shanshan Wang, 
Chen, Shi, et al., 2015) 
Microcapsules O/W emulsion with spray 
drying 
OSA starch None 15 Tocopheryl acetate Not water 
soluble 




Not stated Not done Total drug release was higher at 
higher temperatures 
(Panyoyai et al., 2017) 
Spray dried 
microcapsules 
O/W emulsion with spray 
drying 
















Not done Adding xanthan gum to the 
particles improved protection 
against oxidation but also 
reduced the total amount of 
CLA released. 
(He et al., 2016) 
Oxidized starch 
microspheres 




















Not done Particles demonstrated rapid 
release in SIF with only 
minimal release in SGF. 
Stability of beta-carotene was 
improved through encapsulation 
in particles. 
(Shanshan Wang, 




O/W emulsion with spray 
drying 
OSA starch Soy protein 
isolate 
0.8-16.4 beta-carotene Not water 
soluble 
Emulsification During Not provided 21-39% Not done - - Improved drug 
stability 
Not done Blended particles with both soy 
protein isolate and starch 
provided higher encapsulation 
efficiency but lower 
redispersion compared to 
particles with only starch. 




O/W/O emulsion with 
solvent evaporation 




Emulsification During Up to 932.3 
mg/g 
92-97% Into diluted rat 
caecal content 
~6 hours ~16 hours Colon-targeted 
release 
With rats In vivo studies indicated 
selective release into the colon 
with minor release occurring in 
the stomach and small intestine. 




O/W/O emulsion with 
solvent evaporation 
Rice starch None 111-485 Metronidazole Moderately 
water soluble 
Emulsification During Up to ~778 
mg/g 
76-91% Into goat caecal 
content 
~4 hours ~20 hours Colon-targeted 
release 
With rats In vivo studies indicated 
selective release into the colon 
with minor release occurring in 
the stomach and small intestine. 
(Ahmad, Akhter, 
Ahmad, et al., 2012) 
Starch film-coated 
microparticles 
Spray coating of drug-
containing cores 
Debranched high 





5-ASA Low water 
solubility 
Spray coating During ~16% Not provided Into SGF and 
SIF 
~1 hour ~4 hours Colon-targeted 
release 
With mice A thicker outer coating layer 
lead to less drug release. In vivo 
results showed colon targeting 
capability. 
(J. Chen et al., 2018) 
Starch film-coated 
microparticles 






~600 5-ASA and insulin Low water 
solubility 
Spray coating During 800 mg/g N/A Into SGF for 2h, 
SIF for 6h, and 
SCF for 8h 





Higher resistant starch content, 
higher coating thickness, and 
longer heat treatment time all 
slowed the release of 5-ASA 
from the particles (data only 
provided for 5-ASA) 
(Situ et al., 2014) 
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 Drug loading 
Drug loading is clearly a key step in creating a drug delivery system. Two important classifiers in drug 
loading are (a) whether the loaded drugs are hydrophobic or hydrophilic and (b) whether drugs are loaded 
during or after the particles are formed. Typically, when drugs are loaded during particle formation, the 
drugs are held within the particles by physical entrapment, the result of the physical barrier created by outer 
layers of particle. When drugs are loaded after the particles have been created, typically the drugs must 
diffuse into the particles, with the primary mechanism being adsorption. It is also conceivable to use a 
hybrid method, whereby particles are loaded through adsorption but then an outer layer is added to the 
particles to “lock in” the adsorbed drugs. The method used to load the drugs depends on the method for 
producing the microparticles and on the type of drug being loaded. Due to its hydrophilic nature, starch is 
best suited for encapsulating hydrophilic drugs. Loading of hydrophobic drugs is possible as well, but often 
requires modifications to the starch. 
Drug loading capability depends on the nature of the microparticles, how the microparticles are formed, at 
what point the drugs are loaded into the particles, and the nature of the drugs (e.g. size, charge, 
hydrophilicity, and functional groups). Both small molecule drugs and large molecule drugs (typically 
proteins) can be encapsulated with starch-based microparticles. Loading is typically characterised through 
evaluating the drug encapsulation efficiency (EE) and the drug loading capacity (LC), also known as drug 
retention. While some authors take liberties with how these terms are defined, EE is typically defined as 
EE = (drug loaded into and/or onto the particles)/(total drug used for the loading process), and LC is 




2.4.1 Loading of hydrophilic drugs 
When drugs are loaded through soaking microparticles in a solution with the drug, the method is a somewhat 
agnostic formation method. The loading capacity primarily depends on how much of the particle’s polymer 
mesh is accessible to the drugs, and on the net strength of the intermolecular forces between the drug and 
the polymer mesh are. The surface area accessible to the drugs depends on the porosity and pore size of the 
mesh, in addition to the diffusibility of the drug. Typically adsorption equilibrium is reached within a few 
hours (El Mouzdahir et al., 2007; Yuan Li, Kadam, et al., 2012; Yuhua Li et al., 2019), as long as adsorption 
is not significantly hindered by diffusion. 
Adsorption can be used to load microparticles with hydrophilic drugs to a high loading capacity. While 
there are numerous theories that describe adsorption behaviour, the primary factors that affect capacity 
loading of a specific drug are the equilibrium concentration of the drug and the accessible mesh surface. 
Typically, adsorption capacity is measured in units of mass of drug loaded to mass of microparticle. 
Yuan Li et al. (2009) and Zhao et al. (2015) have completed some foundational work in evaluating the 
adsorption capability of starch-based microparticles, particularly with hydrophilic molecules. Both sets of 
work used two different methods to create the microparticles; however, the result of both are cross-linked 
(either with STMP or GDGE) microparticles made from oxidized starch, which the authors claim to have 
the same physicochemical properties. Lysozyme (MW: 14.3 kDa) was loaded into the particles through 
adsorption, which was able to be loaded to a capacity of 5 g/g (L. Zhao et al., 2015). Loading, as measured 
through adsorption capacity, was dependent on the degree of oxidation of the starch, the pH of the loading 
solution, salt concentration, and cross-linking extent (Yuan Li et al., 2009; L. Zhao et al., 2015). The use 
of oxidized starch to create the particles conferred a highly negative charge to the particles that allowed for 
high loading of the positively charged lysozyme. In other research, Li et al. (2012) created their particles 
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loaded with lysozyme, but then they used polyelectrolyte complexation to create a shell on the outside of 
the particles with poly-lysine and poly-glutamic acid. This shell added an additional barrier between the 
encapsulated lysozyme and the external environment that slowed release of the lysozyme. Z. Wang et al. 
(2013) created particles with the same method and loaded them with anthocyanins (MW: 271- 331 g/mol), 
which are positively charged, to a maximum capacity of 62 mg/g. This comparison indicates that proteins 
are capable of higher loading than small molecule drugs. 
Zhang et al. (2014; 2015) created starch-based microparticles made from carboxymethyl starch (CMS) that 
were intended for delivery of hydrophilic drugs. Particles were created with only CMS, and also with both 
CMS and cyclodextrin. Both lysozyme and ascorbic acid were loaded with lysozyme to a maximum loading 
capacity of about 6 g/g (2014). This loading was about 3x higher than that of ascorbic acid which had a 
maximum loading capacity of 1.9 g/g (2015). The group found that higher amounts of b-cyclodextrin led 
to higher loading capacity of ascorbic acid (2015). 
Small molecule dyes are commonly used to assess the adsorption properties of starch-based microparticles. 
Methylene blue has been loaded into microparticles made from a W/O emulsion and STMP cross-linking 
process; loading capacity was affected by loading temperature, loading time, loading concentration, and 
dissolution medium, with a maximum loading of 327.3 mg/g (Fang et al., 2008). Microparticles made from 
debranched starch and chitosan were successfully loaded with Evans blue and Brilliant blue (Luo et al., 
2019). Although both these dyes have negative charges, the particles had a positive zeta potential due to 
the addition of chitosan, which allowed for loading of up to about 200 mg/g. The same microparticles failed 
to encapsulate two positively charged molecules with low molecular weight (Luo et al., 2019). 
It is also possible to load microparticles with hydrophilic drugs in a method similar to adsorption through 
freeze drying or spray drying. While the drugs are not adsorbed in the strict sense, such loading more closely 
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resembles adsorption than physical entrapment by the particles. This method also allows for higher loading 
than would be possible with only adsorption, but most of the drug will be released nearly instantly. 
Tranexamic acid was loaded into starch microparticles through a combination of adsorption and freeze 
drying up to a loading capacity of 100 mg/g. However, the authors did not characterize how much was 
actually adsorbed prior to the lyophilization step. Spray drying was used to load ascorbic acid into 
microparticles made from aggregated taro starch granules with a loading capacity of 20.9 mg/g (Hoyos-
Leyva et al., 2018). Similar work was also previously conducted using fully gelatinized starch to 
encapsulate ascorbic acid with spray drying which had a maximum loading capacity of up to 98 mg/g 
(Palma-Rodriguez et al., 2013). 
Other non-adsorption-based methods that rely on physical entrapment are often used for encapsulation of 
hydrophilic drugs. Ionic gelation has been used to form particles by dripping carboxymethyl starch and 
alginate, which are both negatively charged, along with diamine oxidase into a solution with Ca2+, which 
acted as the counter ion (Blemur et al., 2016). Polyelectrolyte complexation was used by Quadrado and 
Fajardo (2020) to encapsulate BSA as a model protein to about 100 mg/g with carboxymethyl starch (CMS) 
and chitosan as counter polyelectrolytes. 
Comparison of loading capability between microparticle DDSs can be hard as there is little consistency 
between studies. We suggest that if a study is trying to provide proof of concept for a DDS, then at least 
one commonly-used model drug should be used, depending on the final application intent. BSA and 
lysozyme are already commonly used as model proteins, which is helpful, but establishing commonly-used 
model cationic, anionic, and neutral small molecule drugs and large non-protein drugs could be helpful for 
the field. Such overlap with model drugs can also assist reviewers, and authors themselves, with evaluating 
validity of the study results. 
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2.4.2 Loading of hydrophobic drugs 
Starch-based microparticles can be loaded with hydrophobic drugs in a variety of ways. A common method 
is to modify the hydrophilic starch to introduce hydrophobic domains, allowing for encapsulation of 
hydrophobic molecules. Tocopheryl acetate (MW: 473 g/mol) was loaded into microparticles made from 
octenylsuccinyl-ated starch through spray drying (Panyoyai et al., 2017). The drug was loaded prior to spray 
drying through dissolution, along with starch and ethanol. Solvent diffusion or extraction using an O/W 
emulsion is also a convenient way to load hydrophobic drugs and has been used to load repaglinide (MW: 
453 g/mol) and dexamethasone (MW: 392 g/mol). Repaglinide was loaded into acetylated starch 
microparticles by dispersing a solution containing the drug, starch, and chloroform into water (Okunlola et 
al., 2017). Similarly, dexamethasone was loaded into microparticles made from a blend of starch and 
polycaprolactone by adding the drug with the starch mixture in methylene chloride into a water-soluble 
polymer solution (Balmayor, Tuzlakoglu, et al., 2009). The methylene chloride is extracted out of the 
particles in the O/W emulsion with vacuum drying, leaving the drug-loaded microparticles. Microparticles 
made with a W/O emulsion can also be used to encapsulate hydrophobic drugs and has been used to 
encapsulate furosemide (MW: 331 g/mol) with carboxymethyl starch-based microparticles (Lemieux et al., 
2015) and to encapsulate curcumin (MW: 368 g/mol) with vinyl-functionalized starch microparticles 
(Pereira et al., 2013). These methods are made possible by modifying the solubility of the drug during 
loading. Extrusion spheronization has been used to encapsulate mesalazine (aka 5-aminoslicylic acid) 
(MW: 153 g/mol) by creating a core made from the drug and then coating the outside with modified 
(debranched and retrograded) starch (J. Chen et al., 2018; Situ et al., 2014). 
Microporous materials can be particularly advantageous for delivery of crystalline drugs that have low 
water solubility. By restricting the drug’s ability to form large crystals within the microparticle, surface 
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area can be maximized, and dissolution can occur faster, thus increasing the bioavailability. Lovastatin 
(MW: 405 g/mol) (Jiang et al., 2014) and nitrendipine (MW: 360 g/mol) (Y. Zhao et al., 2015), both 
sparingly soluble in water, were loaded into starch microparticles by soaking the particles in organic 
solvents containing the solubilized drugs. Vacuum dying caused the drugs to precipitate onto and into the 
particles, but the starch prevented large crystals from forming. Both systems demonstrated higher 
subsequent dissolution rates of the drugs into aqueous solutions. Another way in which starch 
microparticles can encapsulate hydrophobic drugs is through use of a O/W/O emulsion. This was 
demonstrated by Wang et al. to encapsulate b-carotene with a LC of 2.3 mg/ mixed with corn oil within an 
outer shell made from cross-linked starch (Shanshan Wang, Chen, Liang, et al., 2015). Wang et al. 
(Shanshan Wang, Chen, Shi, et al., 2015) also encapsulated b-carotene with a slightly different variation 
using a whey protein isolate to stabilize the oil into a nanoemulsion that was then absorbed into cross-linked 
oxidized starch microparticles; the authors reported low release in simulated gastric fluid and high release 
in simulated intestinal fluid.  
 Drug release 
Drug release from starch-based microparticles is the most important aspect of a DDS. For a starch-based 
system, release is dependent on the nature of the particles themselves, their environment, and the 
encapsulated drug. When release is tested in vitro, the testing method used is important for characterising 
release.  Due to the size of microparticles, they are primarily used for either controlled release or sustained 
release. Since the field of research on starch microparticles for drug delivery is still relatively young – 
compared to conventional drug delivery –  and small, most work has focused on in vitro testing. However, 
some in vivo studies with animal models have also been conducted. 
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Through testing the release in vitro, much can be learned about the nature of the particles. Typically, this is 
done by placing the particles into either (a) a solution of PBS (sometimes with enzymes), (b) into simulated 
gastric fluid (SGF, pH 1.2) and simulated intestinal fluid (SIF, pH 6.8), or (c) SGF, SIF, and simulated 
colonic fluid (SCF, pH ~7). Generally testing is done at 37˚C to mimic human body temperature. Since 
release testing into PBS is fairly simple, it makes it easier to isolate the release mechanism. However, its 
usefulness is limited since it is not similar to how the system would respond if taken orally. When release 
is tested, the data is often fit to a drug release model (e.g. zero order, first order, Higuchi, etc.) to evaluate 
the nature of the release. For example, Pereira et al. (2013) fit their release data to four different models 
and found that it was best fit with the Hixson-Crowell model, which indicated that the particles are eroding 
as drug is released. 
In cases where the drug is loaded through adsorption after particle formation, release is typically governed 
by desorption. Release can also be done in various conditions to evaluate the effect of each. Bao Zhang et 
al. (2014) loaded their carboxymethyl starch microparticles with lysozyme through adsorption and found 
that release was highly dependent on release media pH and ionic strength. Greater release at higher pHs 
and higher ionic strength was observed, due to decreases in the binding affinity between lysozyme and the 
particles.  
Sometimes the particles are separated from the release media with a dialysis membrane. One limitation to 
dialysis is the diffusion of drug through the dialysis membrane. When release is relatively quick, it is 
possible that this diffusion can affect the results, depending on the size of drug and the dialysis membrane 
molecular weight cut off (MWCO). If proper controls are done with the non-encapsulated drug, this effect 
can be controlled for. However, a number of published manuscripts lack such a control. 
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Often, when selective release into the small intestine is desired, drug release into SGF is first done, followed 
by release into SIF. The ideal result is no release into SGF, but quick release into SIF. Such a system was 
created by Luo et al. (2018), where their starch microparticles loaded with dyes demonstrated minimal 
release into SGF, but released ~50% of the encapsulated dyes when in SIF within ~5 hours.  
The addition of amylase, which degrades starch, also increased the rate of drug release, as expected. The 
addition of a-amylase increased the rate of release of FD70 and FITC-IgG from HES-based microparticles 
(Wöhl-Bruhn et al., 2012) and of insulin and BSA from starch microparticles (Elfstrand et al., 2009). 
One aspect that could be improved in the field of testing drug release is standardization of release testing 
methods to allow for comparison between studies. Consistency with release media, release times, and 
reporting of the results would help to advance the field. In addition, proper controls must be used to evaluate 
the effect of each variable; too often these are not done. When release studies are done into SGF followed 
by release into SIF, the effect of each by itself cannot be known over the total release time; we suggest that 
controls for release into each SGF and SIF be done. 
When evaluating in vitro drug release over time, there are generally three ways to report the same data. The 
first is to report the cumulative amount of drug released in weight or moles. The second is to report the 
cumulative percentage release of encapsulated drug – often the final release percentage is less than 100%. 
The third is to report the cumulative percentage of the total releasable drug – this value should be 100% at 
the final time point. The second method is most commonly used. We suggest that the drug release be 
reported in all three ways for proper comparisons to be made. In some systems (e.g. a degradable system), 
it is expected that the encapsulated drug and total releasable drug is equivalent as time approaches infinity. 
It is also important that experiments are conducted for long enough to reach equilibrium. Another reporting 
method that would enable comparison between studies is to report the time it takes for 50% (t50%) (J. Li & 
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Mooney, 2016; Yuan Li, Zhang, et al., 2011; Okunlola et al., 2017) and/or 90% (t90%) (Lemieux et al., 2015; 
Lenaerts et al., 1991) of the total releasable drug to be released; releasable drug should be used (as opposed 
to unencapsulated drug) as it is more representative of how the microparticles would release the drug for in 
a medical application and allows for useful comparisons. It is also worth mentioning that if sustained release 
is desired, even if a particular drug/microparticle combination demonstrates burst release followed by 
sustained release, a possible solution could be to cause the burst release to occur in vitro before using the 
DDS for in vivo treatment. 
 Pharmaceutical applications 
Since the field of starch-based microparticles for drug delivery is still a relatively new and small field, there 
appear to be no pharmaceutical products on the market currently. However, we briefly discuss some 
intended applications. 
Colon-targeted and intestine-targeted delivery is the primary goal of most research, and most in vivo studies 
have had this application in mind. Particles must encapsulate drugs and then selectively release the drugs 
into either the small intestine or the colon. By creating particles which are pH and enzyme responsive, such 
selective release can be achieved, as previously described. Oral delivery of quercetin loaded microparticles 
allowed for selective delivery to the small intestine with in vivo testing on rats (D. Li et al., 2020). In a 
number of other studies, specific delivery of various drugs to the colon has been demonstrated (Ahmad et 
al., 2013; Ahmad, Akhter, Ahmad, et al., 2012; Ahmad, Akhter, Anwar, et al., 2012; J. Chen et al., 2018). 
Oral delivery of insulin-loaded starch-coated microparticles also reduced glucose plasma concentrations to 
a similar extent, compared with subcutaneous injection in rats (Situ et al., 2014, 2015), potentially paving 






Starch-based particle systems are a promising method for drug delivery. In addition to being widely 
available, starch has many properties that make it a great contender for use in drug delivery including 
biocompatibility, low toxicity, and high tunability. The methods for producing starch-based particles have 
been well researched and there are a wide variety of methods that may be used to create drug delivery 
systems. A combination of the synthesis methods is often used to create the best system possible for the 
delivery mechanism desired. Research on loading and release of drugs has been conducted with a number 
of starch-based microparticle systems and has demonstrated significant potential. This research has mostly 
focused on in vitro studies and leaves much work to be done on testing in vivo efficacy. 
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Chapter 3: Helium Ion Microscopy of Corn Starch 
This chapter is modified from a published short communication as follows: 
Wulff, David, Marc G. Aucoin, and Frank Gu. 2020. “Helium Ion Microscopy of Corn Starch.” Starch - 
Stärke 1900267. 
Other types of starch (potato, wheat, and Hylon VII starch) were imaged but not included in the manuscript 
and are provided in Appendix A. 
 Summary 
Normal corn starch granules were imaged using a helium ion microscope (HIM). This relatively new 
imaging technique produced high-resolution images of both the interior and exterior of the granules that 
allowed features to be observed which had previously not been seen with SEM. Of particular interest is the 
mesh-like structure which was observed in the interior when starch granules were sectioned with a metal 
blade, a structure not currently part of existing models of starch architecture. HIM imaging provides a new 
way to characterize starch in the ongoing quest to elucidate its internal structure. 
 Introduction 
Helium ion microscopy (HIM) is a relatively new characterization method that utilizes a gas field ionization 
source to create He+ ions. The impact from the beam of He+ ions that are scanned across the sample 
generates secondary electrons, which are then detected. HIM offers high source brightness, low energy 
spread, and small diffraction effects to produce high contrast, high depth-of-field images (Ward et al., 
2006). These properties make the technique a useful tool for nanoscale research. Helium ion microscopy 
has been used for imaging nanoporous SiO2 (Burch et al., 2018), cellulose nanofibrils (Ketola et al., 2019), 
mammalian cells (Sato et al., 2018), and other biological samples (Joens et al., 2013). To the best of our 
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knowledge, we report on the first time that HIM has been used to image starch. Despite much research into 
the structure of starch, unknowns still remain. In particular, the proposed blocklet structure (Gallant et al., 
1997) still has not been clearly defined or characterized. Further, the molecular arrangement of amylopectin 
within starch granules is still an active area of research (Bertoft, 2017). Use of HIM for studying both 
internal and external starch structure can assist with answering these questions. 
The present study achieved high-resolution HIM images of the interior and exterior of normal corn (maize) 
starch granules, allowing new features smaller than 10 nm to be resolved, previously unseen through the 
use of SEM imaging. We contrast our HIM images with similar SEM images. Interestingly, we did not 
observe any blocklet-like structures in either the interior or exterior of granules. It is also worth noting that 
in addition to our HIM images being very high-resolution, the SEM images which we produced for 
comparison are the highest-resolution SEM images of starch of which we are aware. 
 Materials and methods 
3.3.1 Materials 
Unmodified normal corn (maize) (S4126, Lot #: MKBT0621V) starch was purchased from Sigma-Aldrich 
(Oakville, Canada). The apparent amylose content of the starch was 27.8% as determined the method of 
Williams et al. (Williams et al., 1970). A moisture content of 14.3% was determined by calculating the 
difference in weight as a fraction of the initial weight after drying for 16 hours at 100˚C. The granules used 
for microscopy were not the same granules used in the amylose content or moisture test and were not 





3.3.2 Imaging of starch 
A thick mixture of starch in water was created by combining 250 mg of corn starch with 250 µL of water 
in a 1.5 mL centrifuge tube. The mixture was frozen by directly immersing the tube in liquid nitrogen. The 
frozen starch-and-water pellet was removed from the tube and mounted to a cold (-18˚C) metal disc using 
optimal cutting temperature (OCT) compound (VWR, Mississauga, Canada), which rapidly freezes to keep 
the sample in place. The pellet was then sectioned, while still frozen, in 10 µm increments using a 
cryomicrotome (Shandon Cryomicrotome SME, Thermo, Mississauga, Canada) with a metal triple-facet 
cryomicrotome blade (VWR, Mississauga, Canada). The part of the pellet that was sectioned was not in 
contact with the OCT fluid. The sectioned starch granules were placed in a new 1.5 mL microcentrifuge 
tube and washed with an excess of acetone (1 mL) to remove any water. After centrifuging the samples 
(1000 g for 1 min) and decanting the excess acetone, the samples were placed in a vacuum desiccator for 4 
hours to remove the acetone.  The dry samples were lightly sprinkled onto double-sided carbon tape 
attached to the specimen stubs. Gold sputtering was performed for 60 seconds for an approximate coating 
thickness of 5 nm. A (scanning) helium ion microscope (Orion Plus HIM, Carl Zeiss, North York, Canada) 
at a working distance of 6-7 mm, a dwell time of 0.2-1 µs, and a beam current of about 1 pA was used to 
collect the HIM images. A scanning electron microscope (SEM, Quanta FEG 250, FEI, USA) at 20-30 keV 
with a working distance of 9-10 mm was used to produce the SEM images. 
 Results and Discussion 
To compare the imaging capability of HIM to that of SEM, we imaged granules using both microscopes. 
The native corn starch granules had been subject to the exact same preparation method for both types of 
imaging. However, due to the sectioning process, not all particles are sectioned, and, if a particle is 
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sectioned, there is variation in where across the particle it is sectioned. In addition, orientation of the 
particles varies, and the particles can only be imaged from the top. The images presented here are 
characteristic of the numerous images taken and showcase the three different perspectives: 1) the interior 
of particles which do not display an internal cavity, 2) the interior of particles which do display an internal 
cavity, and 3) the exterior of particles. 
Figure 1 features sectioned granules that do not reveal an internal cavity. The granules might indeed have 
internal cavities; however, the observation of the cavity is dependent on both the sectioning and the location 
of the cavity. A comparison between Figs. 1A and 1C demonstrates the general difference between SEM 
and HIM images at relatively low magnification. The HIM imaging capability at high magnification is most 
clearly seen by comparing Figs. 1B and 1D, which are images of regions in Figs. 1A and 1C, respectively. 
In Fig. 1B, a mesh-like structure can be clearly seen. The mesh-like structure has “bundles” which are 
roughly 10-40 nm in thickness with pore sizes roughly 5-50 nm in size. Some of the pores seem to lead 
further into the granule which could play a role in starch porosity. Neither of the prominent models of starch 
structure, namely the “cluster model” and the “building block backbone model”, which are based on 
characterization using AFM, NMR, SEM, WAXS, SAXS, SEC, and DSC, explicitly describe such a mesh-
like structure. Small angle X-ray scattering (SAXS) shows a 9-10 nm repeat distance which has been 
suggested to be the result of repeating crystalline and amorphous lamellae, however there does not seem to 
be much similarity between the bundles seen in these HIM images and the repeating lamellae structures. 




Figure 3.1: Comparison of HIM and SEM images of the interior of sectioned normal corn starch without an 
observable internal cavity. (A) An HIM image of the sectioned granule and (B) a high-magnification image of 
the area demarcated by the black square in (A). (C) An SEM image of a comparable sectioned granule and 
(D) a high-magnification image of the area demarcated by the black square in (C). 
Figure 3.2 shows granules in which an internal cavity was observed. Most native granules have an internal 
cavity (see Chapter 4). The comparison between the HIM images (Figs. 3.2A and 3.2B) and SEM images 
(Figs. 3.2C and 3.2D) demonstrates the difference in imaging quality between the two microscopy methods. 
In both Fig. 2A and 2C, growth rings are observed. The better resolution that HIM provides is most clearly 
seen in Fig. 2B where a mesh-like structure may be observed. When compared to the SEM image at 
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equivalent magnification (Fig. 3.2D), a heterogenous surface is observed, but it is hard to determine what 
that heterogeneity represents. 
 
Figure 3.2: Comparison of HIM and SEM images of the interior of sectioned normal corn starch with an 
observable internal cavity. (A) An HIM image of the sectioned granule and (B) a high-magnification image of 
the area demarcated by the black square in (A). (C) An SEM image of a comparable sectioned granule and 
(D) a high-magnification image of the area demarcated by the black square in (C). 
In addition to imaging the interior of granules, the exterior of native corn granules was also imaged (Fig. 
3.3) which displays the surface morphology. The HIM images (Figs. 3.3A and 3.3B) provide a clearer 
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illustration of the morphology compared with the SEM images (Figs. 3.3C and 3.3D). The high-
magnification images (Figs. 3.3B and 3.3D) both show surfaces with heterogenous roughness. The high-
magnification HIM image (Fig. 3.3B) provides higher differentiation of the various ridge-and-valley 
features compared with the high-magnification SEM image (Fig. 3.3D). Unlike the images showing the 
interior of the granule (Figs. 3.1 and 3.2), the surface doesn’t appear mesh-like. The ridges and valleys 
observed are roughly 20-80 nm across and seem to have depths on that same scale, with both having large 
variation in the shape. The height variation is comparable to that seen with AFM, with the authors 
attributing the unevenness to “blocklet” structures (L. Chen et al., 2019; Ohtani et al., 2000). It is also 




Figure 3.3: Comparison of HIM and SEM images of the exterior of normal corn starch. (A) An HIM image of 
the granule and (B) a high-magnification image of the area demarcated by the black square in (A). (C) An 
SEM image of a comparable granule and (D) a high-magnification image of the area demarcated by the black 
square in (C). 
Interestingly, structures that should also be visible at these when resolving down to about 5 nm are so-called 
blocklets, which are supposed to have diameters in the range of 10-500 nm, depending on the starch type 
(Bertoft, 2017). After Gallant et al. (1997) reported evidence for these structures in 1997, they have been 
widely mentioned in literature, primarily with AFM evidence, in various starch types. There are, however, 
conflicting results in the literature on the properties of blocklets. In particular, there is no consensus on 
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blocklet sizes. Although different sizes of blocklets would be expected with different starch types due to 
considerable variation in granule size and other properties, we would at least expect similarity between the 
same starch types. Ridout et al. (2002) reported blocklets on the surface of corn starch  granules on the 
order of 45-85 nm in size while Park et al. (2011) described small 20-30 nm blocklets within larger blocklet 
structures of 100-200 nm. Baker et al. (2001) have reported blocklets in the interior after sectioning corn 
starch in an embedding resin; they reported observing large 400-500 nm blocklets in native starch granules 
and smaller 10-30 nm blocklets in acid-treated starch granules. Tsukomoto et al. (2012) reported blocklets 
being approximately 30 nm in size (without any treatment). Although presumably all publications were 
referring to blocklet diameter, only Baker et al. specified that this was the case. Regardless, our HIM (and 
even SEM) results challenge the notion that blocklets are a part of starch structure. If these elusive blocklets 
are indeed a real sub-structure of starch, they have not been well defined, and evidence for their existence 
in the literature is relatively weak. Although the purpose of this research was not to investigate blocklets, 
further investigation into blocklets using HIM will be useful. 
 Conclusion 
Helium ion microscopy is a new and exciting technique that has found uses in many applications, and now 
has been shown to be a valuable method for imaging starch. It is capable of resolving features smaller than 
10 nm in size and has been able to reveal new levels of organization within normal corn starch that have 
not been observed before with SEM or AFM. In the interior of native corn starch, there appears to be a 
mesh-like structure which appears porous. On the exterior of native corn starch, clear ridge-and-valley 
morphology can be clearly seen. With further HIM imaging of starch, it should become possible to better 
understand its complicated structure. 
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Chapter 4: Characterizing internal cavity modulation of corn starch 
microcapsules 
This chapter is a published research article as follows: 
Wulff, David, Ariel Chan, Qiang Liu, Frank X. Gu, Marc G. Aucoin. “Characterizing internal cavity 
modulation of corn starch microcapsules.” Heliyon, Volume 6, Issue 10, 2020, e05294. 
 Summary 
Swelling of normal corn starch granules through heating in water leads to enlargement of the starch particles 
and a corresponding increase in internal cavity size. Through control of the swelling extent, it is possible 
to tune the size of the internal cavity for the starch microcapsules (SMCs). The swelling extent can be 
controlled through regulation of the swelling time and the swelling temperature. Since the swelling extent 
is correlated with particle size and solubility, these aspects may also be controlled. Imaging the SMCs at 
increasing levels of swelling extent using scanning electron microscopy (SEM) allowed for the internal 
cavity swelling process to be clearly observed. Brightfield and polarizing light microscopy validated the 
SEM observations. Confocal laser scanning microscopy provided further validation and indicated that it is 
possible to load the SMCs with large molecules through diffusion. The highly tunable SMCs are novel 




Figure 4.1: Graphical abstract for publication 
 Introduction 
Starch is one of the most widely used biopolymers. In addition to its primary use as an energy source in 
food, starch has been used, typically with modifications, in the pharmaceutical, packaging, paper, plastic, 
cosmetic, and medical industries (Q. Liu, 2005). Despite extensive research over the past many decades, 
starch structure is still not fully understood (Bertoft, 2017; Zhu, 2018). Starch granules are particles with a 
size range of 2-100 µm and are the form in which starch molecules – amylose and amylopectin – are 
organized within plants in a semi-crystalline fashion (Vandeputte & Delcour, 2004). When starch granules 
are heated in the presence of excess water, they swell and, eventually, gelatinize, with enough time and 
heat. Gelatinization is the irreversible process by which starch granules transform from their ordered semi-
crystalline state to a disorganized amorphous state (Ai & Jane, 2015) and is characterized by loss of granule 
birefringence and increased suspension viscosity (Markus Schirmer et al., 2015). Although gelatinization 
is typically done by heating starch granules, the same result can be achieved using high hydrostatic pressure 
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(Schneider Teixeira et al., 2018) and can be affected by pH and osmolarity (Simonin et al., 2011).  
Gelatinization occurs gradually, both within each granule, and with all of the granules collectively in the 
sample. Gelatinization is an important process for improving the usability of starch and is used in various 
industries (Builders & Arhewoh, 2016; Ratnayake & Jackson, 2007). Although most aspects of the 
gelatinization process are well characterized and understood (Ai & Jane, 2015; Markus Schirmer et al., 
2015; Waigh et al., 2000), the changes to the internal macrostructure of starch through gelatinization have 
not been clearly elucidated. 
It is well known that many types of starch have granules which can have an internal cavity or hole in their 
native state. These cavities have been reported in starch granules originating from rice (Baldwin et al., 1994; 
Sujka & Jamroz, 2013), wheat (Baldwin et al., 1994; Sujka & Jamroz, 2013), potato (Baldwin et al., 1994; 
Hall & Sayre, 1970; Sujka & Jamroz, 2013), sorghum (K C Huber & BeMiller, 2000), waxy corn (P. Chen 
et al., 2009, 2011), and normal corn (P. Chen et al., 2009, 2011; K C Huber & BeMiller, 2000; Sujka & 
Jamroz, 2013). Although it seems likely that these cavities observed in the native state are at least partly 
the result of drying (Baldwin et al., 1994), the exact origin remains a topic of discussion (K C Huber & 
BeMiller, 2000), and further work is needed. It is understood that the hilum region is an area of low 
organization (Błaszczak et al., 2005) and that gelatinization starts in the hilum region and proceeds radially 
to the periphery of the granule (Jay-lin Jane & Shen, 1993; M Schirmer et al., 2013; Singh et al., 2003b). It 
is likely that these two observations are related, and that gelatinization preferentially occurs in areas with 
less organized structure. As previously mentioned, the internal architecture changes that occur through the 
gelatinization process have been poorly characterized. Some research has observed an internal cavity in 
partially-gelatinized starch (Hall & Sayre, 1971; M Schirmer et al., 2013), but no research has studied the 
progression of that internal cavity at different stages of gelatinization. Little is known about what is 
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happening structurally inside a starch granule as it transitions from a highly organized semi-crystalline 
granule to a highly disorganized amorphous state through the gelatinization process. It is also worth noting 
that some research has characterized the remaining nonsoluble parts of fully-gelatinized starch granules, 
often referred to as “ghosts”. These ghosts form when starch is gelatinized with little or no shear, producing 
structures which are hollow, highly swollen, fragile, and amylopectin-rich (Debet & Gidley, 2007; Gómez-
Luría et al., 2017; Bin Zhang et al., 2014). 
In this paper, we have studied the swelling process as a result of partial gelatinization and the resulting 
structural changes that occur. We use the term “partial gelatinization” to refer to starch granules which have 
been swelled but would not be considered fully gelatinized, and we refer to these particles as starch 
microcapsules (SMCs). The swelling extent (i.e. how swelled the particles are) is characterized through 
measurement of the swelling power. The internal structure of the corn starch was observed at various stages 
of swelling through characterization with scanning electron microscopy, brightfield microscopy, polarizing 
light microscopy, and confocal laser scanning microscopy. In addition to achieving our objective of 
characterizing the swelling process, we also determined that the SMCs which we created can be modulated 
in terms of both the swelling extent and the internal cavity size through a simple heating process. Both the 
swelling process and how the internal cavity changes as a result of the swelling were also mathematically 
modeled and fit to our experimental data. 
 Materials and methods 
Normal corn (maize) starch was purchased from Sigma-Aldrich (S4126, Lot #: MKBT0621V) (Oakville, 
Canada). The apparent amylose content of the native starch was 27.8% as determined by the method of 
Williams et al. (1970). The moisture content was 14.3%, determined by the difference in weight as a fraction 
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of the initial weight after drying for 16 hours at 100˚C. FITC-dextran (MW 10,000) was purchased from 
Sigma-Aldrich. 
4.3.1 Preparation of starch microcapsules (SMCs) through heating in water 
The starch microcapsules (SMCs) were prepared through a simple heat-treatment process. Native normal 
corn starch (0.7 g, dry basis), as received from the supplier, was added with Milli-Q water (14 mL) in a 
centrifuge tube at a concentration of 5% w/w (native, dried starch basis). The term native indicates the 
granules are virgin or unmodified and the term normal distinguishes between other corn starch variants 
(e.g. waxy corn starch). To swell the starch, the centrifuge tube was placed in a water bath at the required 
heating temperature (55-85˚C) for the required time (5-240 min) with stirring of the water bath with a 
magnetic stirrer. The height of the water in water bath was carefully controlled to also cause gentle agitation 
of the centrifuge tube. After the starch was swelled, the starch mixture was cooled immediately to 20˚C by 
placing the centrifuge tube in a cold-water bath. Unless the particles were to be sectioned, the particles 
remained in solution for further use. 
4.3.2 Starch swelling power 
To measure the swelling power, the centrifuge tube containing the mixture of starch (native granules or 
SMC particles) and water were centrifuged at 1000 g for 15 minutes based on the method reported by Kim 
and Huber (2013). The weight of the sediment after decanting the supernatant was then measured. The 







4.3.3 Soluble starch fraction 
We calculated the fraction of soluble starch using the standard approach for starch solubility analysis 
(Shujun Wang & Copeland, 2012) with an alternate method of calculation as noted below. The decanted 
supernatant (from the swelling power measurement step) was added to a pre-weighed glass vial and placed 
in an air oven at 105˚C until at a constant weight (~24 hours). The weight of the dried soluble starch was 
then measured, and the weight loss was used to calculate the amount of soluble starch in the supernatant. 
Since the volume of the supernatant is less than the volume of the water added initially – the result of 
interparticle and intraparticle water – the solubility was corrected by the ratio of these two volumes to 
account for this difference. This correction assumes that all water in the mixture has the same concentration 
of soluble starch, regardless of whether it is the supernatant or interparticle or intraparticle water. The 







4.3.4 Starch granule size distribution 
Starch particle sizes were measured using a laser particle sizer (Fritsch NanoTec Analysette 22, Fritsch 
GmbH, Idar-Oberstein, Germany) using static light scattering. The starch samples were suspended in water 
at a concentration of about 7% (w/w). The surface weighted mean diameter [D(3,2)] (i.e. Sauter diameter) 
was used as the representative diameter. The surface weighted mean is the equivalent diameter of a sphere 





4.3.5 Sectioning of starch for internal particle imaging with SEM and HIM 
After the SMC preparation process, the sediment was frozen through immersion in liquid nitrogen. The 
sample was then mounted to a cold (-18˚C) metal disc using optimal cutting temperature (OCT) compound 
(VWR, Mississauga, Canada), which rapidly freezes to keep the sample in place. The sample was then 
sectioned, while still frozen, in 10 µm increments using a cryomicrotome (Shandon Cryomicrotome SME, 
Thermo, Mississauga, Canada) with a metal triple-facet cryomicrotome blade (VWR, Mississauga, 
Canada). The samples were then placed back in a -20˚C freezer until further use. The part of the pellet that 
was sectioned was not in contact with the OCT fluid. 
4.3.6 Scanning electron microscopy and helium ion microscopy imaging of starch 
The starch samples (native and SMC) were prepared through either a) acetone washing and vacuum drying 
or b) freeze drying to remove residual water. The dried starch samples were sprinkled onto double-sided 
carbon tape attached to the specimen stubs. Gold sputtering was performed for 120 seconds for an 
approximate coating thickness of 10 nm for SEM imaging; 60 seconds was used for HIM imaging. A 
scanning electron microscope (SEM, Quanta FEG 250, FEI, USA) at 20-30 keV with a working distance 
of 9-10 mm was used to produce the SEM images. A (scanning) helium ion microscope (Orion Plus HIM, 
Carl Zeiss, North York, Canada) at a working distance of 6-7 mm, a dwell time of 0.2-1 µs, and a beam 
current of about 1 pA was used to collect the HIM images. Refer to Section 3.3.2 for more details on sample 
preparation for imaging. 
4.3.7 Optical imaging of starch 
The starch samples (native and SMC) were placed on a glass slide, a small drop of water was added, and a 
coverslip was placed on top. The slide was then imaged using an optical microscope (Axioskop, Carl Zeiss, 
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North York, Canada) at 50x magnification. Polarizing light images were taken using the same microscope 
with a set of cross polarizing light filters (Carl Zeiss, North York, Canada). 
4.3.8 Fluorescent microscopy of starch 
Starch samples (native and SMC) were added to a solution of fluorescein isothiocyanate conjugated with 
dextran (FITC-dextran) with a molecular weight of 10,000 g/mol at a concentration of 10 mg/mL and were 
left overnight at room temperature for loading of the particles. Right before imaging (~15-30 min before), 
each sample was placed on filter paper using a pipette to wick away excess liquid and then rinsed using a 
few drops of water. The starch was removed from the filter paper and placed on a microscope slide; a drop 
of water was added, and a coverslip was placed on top. Nail polish was used to seal between the edges of 
the coverslip and the slide to prevent evaporation and movement. Once the nail polish was dry (~5 min), 
the slide was placed on the microscope and images were taken using a confocal microscope (LSM 700, 
Carl Zeiss, North York, Canada) with illumination by the 488 nm laser using a 100x oil immersion 
objective. 
4.3.9 Particle size and internal cavity analysis on SEM images 
SEM images of sectioned particles were analyzed for particle dimensions in Photoshop (Adobe, San Jose, 
CA, USA) using the ruler tool. To calculate the particle diameter, the widest and narrowest diameters were 
measured and the two were averaged to calculate the average diameter for each particle. To calculate the 
internal cavity diameter, the shell thickness was first measured by averaging the thickest and the thinnest 
points of the particle shell and then calculated using Eq. 3:  
internal	cavity	diameter = particle	diameter − (2 ∗ shell	thickness)		 	 (3)	
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A total of eight particles for each particle type were analyzed. The theoretical equation for modeling the 
internal cavity size as a function of the particle size was fitted using the initial hole size (bi). 
4.3.10 Statistical Analysis 
Swelling power experiments were conducted in triplicate or quadruplicate, and values are reported as the 
mean±SD. The data were fitted empirically to model the observed behaviour. Lines of best fit were created 
in Origin graphing and data analysis software (OriginLab, Northampton, MA, USA). For the exponential 
equation fits, the ExpGro2 and ExpGro1 functions were used, representing two-phase exponential growth 
and single-phase exponential growth, respectively. For the sigmoidal equation fit, the Hill1 function was 
used. For the linear equation fit, the Line function was used. For the second order polynomial equation fit, 
a polynomial function with an order of two was used. The equations and fitted parameters are given within 
each plot figure. 
 Results and Discussion 
4.4.1 Preparation of tunable starch microcapsules (SMCs) 
4.4.1.1 Control of swelling power using swelling time 
The tunability of the swelling extent was first studied through measuring the swelling power as a function 
of time (Fig. 4.2). The swelling power was measured at various swelling times with heating at 65˚C and 
70˚C and with no heating (at 20˚C) as a control. All subsequent preparations of SMCs were swelled for 30 
min for two reasons: 1) 30 min allowed for the swelling processes to mostly plateau as seen in Fig. 4.2, and 
2) 30 min is also what other work has used to prepare swelled starch particles (Kumar et al., 2018; 
Ratnayake & Jackson, 2007; Shi et al., 2013; W. Wang et al., 2017). The swelling process can be modeled 
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using a second order exponential curve as seen with the solid lines in Figure 4.2. A similar swelling profile 
was observed by Desam et al. with waxy maize starch (2018). Control of swelling time is one way to control 
the swelling extent of the SMCs. 
 
Figure 4.2: The swelling power of corn starch at increasing swelling times with heating at 70˚C and 65˚C, and 
with a swelling control at 20˚C (n=3, mean ± SD).  Exponential functions were fitted to the data, with a two-
phase function used for heating at 70˚C and a single-phase function used for heating at 65˚C. The fitted 
parameters (SPf, final swelling power; A1; x1; A2; and x2) and equations are provided in the inset table. 
4.4.1.2 Control of swelling power using swelling temperature 
The effect of temperature on the swelling power was studied by creating SMCs through heating (for 30 
minutes) at 55˚C (SMC55), 60˚C (SMC60), 65˚C (SMC65), 70˚C (SMC70), 75˚C (SMC75), 80˚C 
(SMC80), and 85˚C (SMC85) (Fig. 4.3). As the heating temperature increases, the swelling power increases 
too. These results indicate that the most significant structural changes occur for the SMC65 and SMC70 
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samples because relative change from the native starch swelling power is the greatest for these two samples. 
The swelling process as a function of temperature can be modeled using a sigmoidal equation. It should be 
noted that the modified Hill equation as we have used it is only valid as a model up to 85˚C. A similar 
sigmoidal swelling profile was observed by Tester and Morrison (1990) when they measured swelling 
factor vs temperature for normal maize starch. Control of swelling temperature is a second way to control 
the swelling extent of the SMCs. 
 
Figure 4.3: The swelling power (SP) of corn starch at increasing swelling temperatures (t) with heating for 30 
min (n = 4, mean ± SD). A modified Hill equation was fitted to the data. The fitted parameters (SPi, initial 
swelling power; SPf, final swelling power; k; and n) and equation are provided in the inset table. 
4.4.1.3 Control of particle size using swelling power 
As the swelling power increases, it is natural to conclude that the particle sizes must increase. Static light 
scattering (SLS) was used to determine particle diameters and to demonstrate the effect of swelling on the 
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particle sizes (Fig. 4.4). Increased swelling temperatures linearly correlates to increased particle sizes. 
Although laser light scattering data can be used to calculate various mean diameters, the mean Sauter 
diameter (d3,2) provided the best fit and thus was used. The Sauter diameter also showed the most similarity 
to diameters observed with other microscopy methods. The correlation between the swelling power and 
diameter can be used to modulate the mean particle diameter. Native starch granules have a polydisperse 
particle size distribution, and so, as expected, the swelled SMCs likewise have a fairly polydisperse 
distribution (Appendix B). It is worth noting that there are many active and passive methods for sorting 
microparticles while in solution (Sajeesh & Sen, 2014; Xi et al., 2017; Zhou et al., 2019), and it is expected 
that these SMCs would similarly be easily sortable based on their size to allow for a more monodisperse 
distribution if needed. 
 
Figure 4.4: The effect of swelling power (SP) on the mean particle diameter (MPD). A linear equation was 
fitted to the data. The fitted parameters (a and b) and equation are provided in the inset table. 
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4.4.1.4 Control of soluble starch fraction using swelling power 
As the particles swell and start to gelatinize, some of the polymer becomes solubilized. The soluble starch 
fraction (sometimes referred to by others as solubility or percent of leaching) can be plotted as a function 
of swelling power (Fig. 4.5). This soluble starch is quite minimal at low swelling powers but does become 
increasingly significant as the swelling power increases. Our data can be fitted through a second order 
polynomial as indicated in Fig. 4.5 by the solid line. The correlation between the swelling power and 
solubility can be used to control the extent of solubilization. 
With normal corn starch, amylose preferentially leaches out (Doblado-Maldonado et al., 2017; Roger & 
Colonna, 1996). Further, the preferential leaching out of amylose in corn starch is more significant at lower 
heating temperatures: Doblado-Maldonado et al. (2017) observed leached material with 91.4% amylose 
content (determined through size exclusion chromatography) with heating at 90˚C, compared with 96.7% 
amylose content with heating at 70˚C (the native starch they used had an amylose content of 28.0%). It has 
also been suggested that that the leaching out of amylose is dependent on starch type (Vamadevan & Bertoft, 
2020). 
A single analysis of the amylose content on our results indicated that the soluble starch from preparing 
SMC70 had 68.6% amylose content, as determined through a colorimetric method (Williams et al., 1970), 
compared with 27.8% amylose content of the native corn starch, further supporting that amylose 




Figure 4.5: The effect of swelling power (SP) on soluble starch fraction (SSF). A second order polynomial 
function was fitted to the data. The fitted parameters (a, b, and c) and equation are provided in the inset 
table. 
4.4.2 Characterization of starch microcapsules 
4.4.2.1 Scanning electron microscopy 
Scanning electron microscopy (SEM) provided clear images of the internal structure of the SMCs in a dry 
state. We observed that most native granules had an empty internal cavity (Fig. 4.6a, 4.6d, and 4.6g). The 
internal cavities were primarily observed as being centred around the hilum region. It has been reported 
that internal cavity formation is the result of drying (through creation of internal stresses) of the granules 
both in potato starch (Baldwin et al., 1994) and maize starch (Kerry C. Huber & BeMiller, 1997). The 
results in Fig. 4.6a, 4.6d, and 4.6g also indicate that the internal cavity is empty, in agreement with work 
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by Huber and BeMiller (2000). In contrast to our results, Gallant et al. suggested the space was filled with 
amorphous material (1997). 
In the particles swelled at 65˚C (SMC65) (Fig. 4.6b, 4.6e, and 4.6h), larger internal cavities were observed 
compared to the native corn starch granules. Particles showed some variation in the appearance of internal 
cavity surface roughness. Of particles which were sectioned and were oriented so that the interior could be 
seen, all showed an internal cavity. In the particles swelled at 70˚C (SMC70) (Fig. 4.6c, 4.6f, and 4.6i), 
even larger internal cavities are seen compared with the SMC65 particles. With heating at 70˚C, the walls 
of the particles become quite thin as a result of particle expansion. 
The primary mechanism for wall thinning and cavity growth is simply particle swelling. With the 
assumption that the starch wall volume and density is conserved, the starch cavity volume can be modeled 
mathematically as the particle swells (see Section 4.3.3). As we have observed that solubilization also 
occurs with particle swelling, this solubilization must contribute either to wall thinning and cavity growth, 
to a decrease in density of the starch wall, or to both. However, if we assume that starch density is constant, 
when the effect of solubilization (using data and correlations in Figs. 4.4 and 4.5) on internal cavity volume 
is calculated mathematically , it is seen that the effect is negligible (proof given in Fig. 4.11).  
Our results support the idea that the starch closest to the hilum region is more loosely packed and hence 
most easily solubilized (Yang et al., 2016). Although there are still conflicting results regarding whether 
there is more amylose or amylopectin in the interior of starch granules (Bertoft, 2017), there is consensus 
that this interior region is more amorphous than the peripheral regions of the starch granule (Buléon et al., 




Figure 4.6: SEM images of sectioned native starch granules (a, d, and g), SMC65 particles (b, e, and h), and 
SMC70 particles (c, f, and i). Particles in images a, b, c, d, and f were acetone washed; e, g, h, and i were 





4.4.2.2 Helium ion microscopy 
Helium ion microscopy (HIM) is a relatively new characterization method which is capable of producing 
high-resolution images of starch, as we have previously reported (Wulff, Aucoin, et al., 2020). The results 
in Fig. 4.7 support what is seen in the SEM images (Fig. 4.6). In native corn starch granules, growth rings 
(Fig. 4.7a) and the surface morphology with a mesh-like structure (Fig. 4.7d) are clearly seen. HIM images 
of SMC65 (Fig. 4.7b and 4.7e) clearly show a distinct internal cavity similar what was seen with SEM. In 
addition, pore-like structures are seen in the wall of the particle. The images of SMC70 particles (Fig. 4.7c 
and 4.7f) similarly supported what we saw observed with SEM. In Fig. 4.7c, the wall of the SMC70 particle 





Figure 4.7: HIM images of sectioned native starch granules (a and d), SMC65 particles (b and e), and SMC70 
particles (c and f). All particles were acetone washed. White boxes in the top images indicate the location of 
the zoomed-in bottom images. Images were taken using a Zeiss Orion Plus helium ion microscope. Scale bars 
indicate 2 µm (top row) and 200 nm (bottom row). Fig. 7a and 7d are adapted and reproduced with 
permission from (Wulff, Aucoin, et al., 2020). 
4.4.2.3 Optical microscopy 
Brightfield images of the swelling process (Fig. 4.8a – 4.8d) clearly show the increase in size as the particles 
are heated at higher temperatures and support the SEM and HIM results, but with particles which are fully 
wet and in solution. The particles also appear to become more translucent at they get larger. The SMC70 
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particles (Fig. 4.8d) have a diameter which is about double compared to the native starch granules (Fig. 
4.8a), roughly in agreement with the quantitative results obtained using the laser particle sizer. 
Polarizing light microscopy allows for insight into the crystallinity of the starch granules. These images 
show the transition from native corn (Fig. 4.8e), which is birefringent (as indicated by the characteristic 
‘Maltese cross’), to nearly complete loss of birefringence when heated to 70˚C (Fig. 4.8h). The ‘Maltese 
cross’ demonstrates radial organization within the starch granule and indicates a high degree of order inside 
the granules (Bertoft, 2017). Loss of birefringence is known to be associated with melting of crystallites 








Figure 4.8: Microscopy images (brightfield, top; polarized light, bottom) of native corn starch granules (a and 
e), SMC60 particles (b and f), SMC65 particles (c and g), and SMC70 particles (d and h). For each sample 
type, the exact same particles were imaged for both brightfield and polarized images. Scale bars indicate 20 
µm. 
4.4.2.4 Confocal laser scanning microscopy 
CLSM images (Fig. 4.9) allowed for internal structures to be seen both in a wet state and without using a 
microtome to physically section the starch. FITC-dextran (MW 10,000) was chosen because it shows clear 
identification of features in starch granules and is not selective with respect to amylose or amylopectin. As 
noted by Schirmer et al., there is little information on the way in which various dyes interact with starch 
granules (2013). Based on our method of preparation, it was possible to qualitatively analyze the diffusion 
of the FITC-dextran after the particles had been washed with water. 
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Native corn starch (Fig. 4.9a) showed some variation between particles with respect to dye localization. 
Some particles showed high fluorescence in the hilum region of the particles while others showed very low 
fluorescence there, in agreement with work by Dhital et al. (2013). This result seems to indicate that, of 
native granules that had an internal cavity in the hilum region, only some were permeable to FITC-dextran, 
which could mean that only some granules have pores or channels which are large enough for FITC-dextran 
to diffuse all the way to the centre of the granule. A similar result was found by Achayuthakan et al. (2012) 
who observed higher permeation in rice starch with MW 4,000 FITC-dextran compared to MW 10,000 
FITC-dextran. In addition, of the particles which were fully permeable to FITC-dextran, the fluorescent 
intensity in the hilum region was very high. Based on the assumption that higher fluorescent intensity means 
higher concentration of FITC-dextran, this higher intensity indicated that the hilum region was empty which 
allowed for higher concentration of the dye. The reason for the lower fluorescence outside of the particles 
in Fig. 4.9a – 4.9c was likely due to the water washing step which dilutes the FITC-dextran. 
In the SMCs (Fig. 4.9b – 4.9d), internal cavities and their expansion were clearly observed. Of particular 
interest is that the particles, particularly SMC60 and SMC65 particles, have varying internal fluorescence. 
When the particles were washed and placed on the microscope slide, the FITC-dextran likely started to 
diffuse out slowly. Of the particles which were both permeable and had a high concentration of FITC-
dextran in the cavity, presumably the particles which displayed higher internal cavity fluorescence when 
imaged had a slower rate of diffusion out of the particles. Relative background fluorescence was brighter 
with the SMC images compared with the native granule image, likely as a result of the FITC-dextran which 
had diffused out of the particles. One final observation is the loss in circularity as the particles swell, which 




Figure 4.9: Confocal laser scanning microscopy images of native corn starch granules (a), SMC60 particles 
(b), SMC65 particles (c), and SMC70 particles (d). Scale bars indicate 20 µm. 
4.4.3 Mathematical modeling of starch swelling 
It is possible to mathematically relate swelled particles sizes to the size of the internal hole. Two 
assumptions must be made: 1) particles are spheres and 2) particle wall volume and density are conserved 
through the swelling process. The swelled microcapsule will have an internal hole radius (rh,s) that is a 
function of the native granule outer particle radius (rp,n), the native granule internal hole radius (rh,n), and 
the swelled microcapsule outer particle radius (rp,s); it can be calculated, through derivation from the 
equation relating the volume of a sphere to its radius using Eq. 4: 
@8,: = A(@;,:)< + (@8,=)< − (@;,=)<	
3 	 	 (4)	
Equation 4 can also be written in an alternative dimensionless form which uses variables to describe the 
relative swelling extent (a) and the relative size of the internal cavity (b). a represents the ratio of swelled 
particle radius to native particle radius, and b represents the ratio of the swelled hole radius to the native 
particle radius (Fig 10). bi represents the ratio of the initial (unswelled) hole radius to the native particle 
radius. These variables are calculated using Eqs. 5-7: 
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Thus, the dimensionless equation now takes the form in Eq. 8: 
b = AG< + b?
< − 1	
3
		 					(8)	 	 	
When plotted (Fig. 4.10), the relationship between a, b, and bi can be clearly seen. The two superimposed 
model particles in Figure 8 demonstrate the swelling process for a granule with bi = 0.4, with the left particle 
being a native granule and the right particle being a swelled microcapsule. A small change in the outer 
particle radius results in a large change in the internal hole radius. It is also clear that the effect of the initial 




Figure 4.10: The effect of particle swelling on internal hole size can be seen by comparing the effect of 
increasing particle swelling extent (a) with various initial hole sizes (bi) on swelled hole sizes (b). The 
superimposed particle section on the left indicates a native (n) starch granule demonstrating the radius of the 
hole (h) and of the outer particle surface (p), and the superimposed particle on the right indicates a swelled (s) 
starch microcapsule (SMC) demonstrating the same radii. 
As indicated previously, the calculation of Eq. 8 assumes conservation of particle wall (i.e. the shell) volume 
and density. However, even when the loss of soluble starch is accounted for by use of the correlations for 
swelling power and solubility in Fig. 4.5, there is a less than 0.35% change in the hole radius at any given 





Figure 4.11: The effect of accounting for material loss when calculating the theoretical hole radius based on 
conservation of mass and density. The calculations are based on an initial particle radius of 4.25 µm, 
representative of native normal corn starch. The swelling power is calculated from the linear line of best fit 
(in Eq. 4), and the fraction of soluble starch is calculated based on the second order polynomial line of best fit 
from the swelling power (in Eq. 5). These calculations assume that a) both the solubilized and unsolubilized 
starch had the same density prior to any solubilization and b) the solubilized starch is only removed from the 
inner surface (i.e. the internal cavity side) of the particle. 
4.4.4 Fitting of mathematical modeling with experimental data 
The theoretical mathematical model in the previous section (Section 4.4.3) can be fit to particle size and 
hole size data based on SEM images of sectioned particles.  Image analysis on native particles, SMC65 
particles, and SMC70 particles yielded values for the relative swelling extent (a) and the relative internal 
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hole size (b), which can be plotted and compared to the model equation. The measured b value for native 
particles gives bi = 0.35±0.08; and this value is the only value needed to fit the model, as seen in Figure 
4.12, which results in a close fit. The standard deviation is primarily a result of variation in particle and 
hole sizes and not measurement error. 
 
Figure 4.12: The experimental particle size and hole data fitted to the mathematical model. The fit for a 
represents the outer particle radius and the fit for b represents the internal hole radius. (n=8, mean ± SD) 
Based on the experimental results, for SMC70 particles the average increase in particle radius is about 39% 
(i.e. a = 1.39±0.22). Based on the fitted mathematical model, a 39% increase in the particle radius results 
in a relative internal hole size increase from 0.35 to 1.20, which means that internal cavity volume increases 





The starch granule swelling process in normal corn starch was studied through heating starch in an excess 
of water. Both the swelling temperature and the swelling time can be used to control the swelling extent of 
the particles, as measured by the swelling power. When the starch is swelled, there is a corresponding 
increase in the average particle diameter and in the amount of soluble starch, allowing for control of these 
properties too. The swelling process causes growth of the internal cavity, as clearly observed with SEM, 
HIM, and CLSM imaging. The growth of the internal cavity is primarily the result of particle expansion, 
and only a small increase in particle diameter corresponds to a large increase in the internal cavity volume. 
The particle shell becomes thinner while the structural integrity of the particle appears to be largely 
maintained. The swelling process was modeled mathematically in close agreement with our experimental 
results.
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Chapter 5: Characterization of swelled normal corn starch and comparison 
with other starch types 
 Summary 
Starch swelling is compared with pea, potato, wheat, waxy corn and normal corn starch through heating in 
water. Morphological changes are observed through brightfield and scanning electron microscopy (SEM) 
with internal cavities and increased particle sizes being observed. Particle size distributions are measured 
and assessed as a result of particle swelling. The effect of centrifugation force on the swelling power is 
evaluated with higher centrifugal force leading to lower swelling power measurements. In pursuit of using 
the particles as an oral drug delivery system, we determined that greatly swelled starch has higher 
digestibility compared to native starch. Cross-linking is demonstrated as a method for inhibiting swelling, 
with corn starch being better inhibited than pea starch. Zeta potentials for corn starch are measured to be 
negative. And it is demonstrated that the normal corn microparticles selectively absorb water in a solution 
of bovine serum albumin (BSA). 
 Introduction 
To use partially swelled starch in a drug delivery system, it is crucial to understand partially swelled starch 
to a reasonable extent. Attempting to characterize drug loading and release without a good understanding 
of the microparticles could make that characterization process more difficult. Comparing different options 
for starch types is also helpful for obtaining the most suitable type. 
In this work, we gain a better understanding of the starch swelling process, the differences between different 




 Materials and Methods 
5.3.1 Materials 
The following samples were purchased from Sigma-Aldrich (Oakville, Canada): normal corn (maize) starch 
(S4126, Lot #: MKBT0621V), wheat starch (S5127, Lot #: 28H1016), waxy corn (maize) starch (S9679, 
Lot #: SLBP9703V), and potato starch (S4126, Lot #: BCBJ1187V). Pea starch was purchased from Nutri-
Pea Limited (Portage la Prairie, Canada). The moisture contents for normal corn, wheat, waxy corn, potato, 
and pea starch were 14.3%, 15.0%, 15.0%, 22.1%, and 14.2%, respectively, determined by the difference 
in weight as a fraction of the initial weight after drying for 16 hours at 100˚C. STMP, NaOH, and NaCl 
were purchased from Sigma-Aldrich (Oakville, Canada).. 
5.3.2 Preparation of starch microcapsules (SMCs) through heating in water 
The starch microcapsules (SMCs) were prepared through a simple heat-treatment process. Native corn 
starch (0.7 g, dry basis), as received from the supplier, was added with Milli-Q water (14 mL) in a centrifuge 
tube at a concentration of 5% w/w (native, dried starch basis). To swell the starch, the centrifuge tube was 
placed in a water bath at the required heating temperature (50-90˚C) for 30 min with stirring of the water 
bath with a magnetic stirrer. The height of the water in water bath was carefully controlled to also cause 
gentle agitation of the centrifuge tube. After the starch was swelled, the starch mixture was cooled 
immediately to 20˚C by placing the centrifuge tube in a cold-water bath. Unless the particles were to be 





5.3.3 Starch swelling power 
To measure the swelling power, the centrifuge tube containing the mixture of starch (native granules or 
SMC particles) and water were centrifuged at 1000 g for 15 minutes based on the method reported by Kim 
and Huber (2013). The weight of the sediment after decanting the supernatant was then measured. The 




5.3.4 Optical imaging of starch 
The starch samples (native and SMC) were placed on a glass slide, a small drop of water was added, and a 
coverslip was placed on top. The slide was then imaged using an optical microscope (Axioskop, Carl Zeiss, 
North York, Canada) at 20x magnification. 
5.3.5 Sectioning of starch for internal particle imaging with SEM 
After the SMC preparation process, the sediment was frozen through immersion in liquid nitrogen. The 
sample was then mounted to a cold (-18˚C) metal disc using optimal cutting temperature (OCT) compound 
(VWR, Mississauga, Canada), which rapidly freezes to keep the sample in place. The sample was then 
sectioned, while still frozen, in 10 µm increments using a cryomicrotome (Shandon Cryomicrotome SME, 
Thermo, Mississauga, Canada) with a metal triple-facet cryomicrotome blade (VWR, Mississauga, 
Canada). The samples were then placed back in a -20˚C freezer until further use. The part of the pellet that 





5.3.6 Scanning electron microscopy (SEM) imaging of starch 
The starch samples (native and SMC) were first frozen in liquid nitrogen and the sectioned using a 
cryomicrotome in 10 µm increments. The still-frozen sectioned granules were then washed with acetone to 
remove water while minimizing the impact of drying on the internal structure. Acetone washing involved 
placing the frozen sectioned granules in an excess of acetone (at room temperature), centrifuging to separate 
the particles, decanting the supernatant acetone, and then placing the granules in a vacuum dryer until dry. 
The dried starch samples were sprinkled onto double-sided carbon tape attached to the specimen stubs. 
Gold sputtering was performed for 120 seconds for an approximate coating thickness of 10 nm. The starch 
was then viewed using a scanning electron microscope (SEM, Quanta FEG 250, FEI, USA, 10-30 keV). 
5.3.7 Starch particle sizing 
Starch granule sizes were measured using a laser particle sizer in wet mode (Fritsch NanoTec Analysette 
22, Fritsch GmbH, Idar-Oberstein, Germany). The starch samples were suspended in water at about 7% 
(w/w). The surface weighted mean (d3,2) was used for further calculations and correlations. Each data point 
represents analysis of over 1,700 particles. 
5.3.8 In vitro starch digestibility and amylose content 
In vitro starch digestibility was determined by using the Englyst method (Englyst et al., 1992) with minor 
modifications. Glucose content of the supernatant was measured by a glucose oxidase-peroxidase assay kit 
(Megazyme International Ireland Ltd., Bray, Ireland). Percentages of rapidly digestible starch (RDS, % 
digestible starch at 20 min), slowly digestible starch (SDS, % digestible starch at 120 − min % digestible 
starch at 20 min), and resistant starch (RS, 100% − % digestible starch at 120 min) were calculated. 
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Apparent amylose content was measured by the method Williams et al. (1970) using  UV-vis 
spectrophotometer to measure the absorbance of the amylose-iodine complex at a wavelength of 625 nm. 
5.3.9 Cross-linking of partially swelled starch 
STMP-crosslinked starch samples were prepared using a modified method of Gao et al. (2014). Starch 
granules were prepared using our standard swelling method with about 1.3 g of normal corn starch in a 50 
mL centrifuge tube. After centrifugation at 1000g for 15 min, the supernatant was decanted leaving the 
starch sediment. For the high STMP treatment, 1 mL of STMP solution (200 mg/mL), 2.5 mL of NaOH 
solution (2 mg/mL), 600 µL of NaCl solution (100 µg/mL), and 10 mL of Milli-Q water were added to the 
swelled starch. The mixture was heated at 50˚C in a water bath with stirring for 80 min. The solution was 
neutralized from a pH of  ~11 to a pH of ~7 using a few drops of 37.5% HCl. 
5.3.10 Zeta potential 
Zeta potential was determined by electrophoretic light scattering in a Zetasizer Nano (Malvern Instruments, 
UK) at room temperature. For the measurements, the previously freeze-dried starch microparticle samples 
were diluted to 0.1 wt.% in a solution of 0.01 mM NaCl at approximately neutral pH. 
5.3.11 Selective water uptake 
Wet starch (native and swelled) was first frozen using liquid nitrogen and then freeze dried to leave only 
the dry starch particles and to preserve the granules and SMCs in their swelled form. 10 mL of BSA solution 
(20 mg/mL) was then added to 0.4g of freeze-dried starch. The starch and BSA solution were then placed 
on a bench rotator overnight. After the elapsed time, the tube was centrifuged for 5 min at 1000 g to settle 
out the starch granules. The supernatant was then filtered using a 0.2 µm filter, diluted 40x with water, and 
the UV-vis absorbance analyzed at 280 nm to determine the concentration of BSA using a standard curve. 
 
82 
The amount of water selectively absorbed was based on a mass balance of BSA based on the observed 
increase in concentration. 
 Results and Discussion 
5.4.1 Comparing the swelling profiles of various starch types using swelling power 
To evaluate the various starch types for suitability for use in a drug delivery system, we compared the 
swelling profiles of several starch types. Swelling power provides a simple and easy way to quantify 
swelling extent. Figure 5.1 demonstrates the differences in swelling power for pea, potato, wheat, waxy 
corn, and normal corn (NC) starch. Experiments were conducted with heating only up to 90˚C as further 
heating leads to disintegration and a loss of rigidity of the particles, making them unsuitable for our 
purposes. For each type, the swelling power increases with increasing swelling temperatures, as expected 
(J. Y. Li & Yeh, 2001). Our goal for evaluating a number of types of starch was to evaluate if certain types 
of starch should immediately be ruled out as potential candidates for a starch-based drug delivery system. 
While other work had studied how the swelling power changes with swelling temperatures (Cai, Cai, et al., 
2014; J. Y. Li & Yeh, 2001; Tester & Morrison, 1990), none had done so across enough types with results 
that were fully comparable. 
For potato starch, the swelling power increased significantly when heated at 60˚C and was unquantifiable 
beyond that point due to an unclear distinction between the supernatant and the swelled starch. A quickly 
rising swelling power for potato starch between 55 and 60˚C could make it difficult to target a specific 
swelling extent if needed for particle design. When evaluating the swelling powers of wheat, pea, waxy 
corn, and normal corn at Tswell = 65˚C, the types swell from most to least in the following order: wheat > 
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pea > waxy corn ≈ normal corn. Based on these results, it seemed that potato starch was likely a poor 
candidate for use in a drug delivery system we were trying to create.  
 
Figure 5.1: The effect of swelling temperature on swelling power of pea, potato, wheat, waxy, and normal 
corn starch. For T ≥ 75˚C, n = 1; all others, n=3, mean ± SD. 
A progression of swelled pea starch and their swelling extent with respect to swelling temperature is seen 
in Figure 5.2. Visually, the samples appear to have the most drastic change in appearance for the 65˚C and 
70˚C samples. When swelled in water with 5% w/w starch content, for the 80˚C and 90˚C samples the 
swelled starch expands to fill the entire volume and were limited by the available water. This observation 
is in agreement with Shujun Wang et al. (2014) where they demonstrated that for heating of wheat starch 
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at 92.5˚C at starch content above 6.66% w/w, the swelling was water constrained. To more accurately 
measure the swelling extent at high temperatures, a lower starch content should be used. 
 
Figure 5.2: Swelling progression of swelled pea starch at increasing swelling temperatures. Temperatures at 
which samples were heated are indicated on the vial lids. Swelling was done for 30 min at a 5% w/w starch 
content. 
5.4.2 Microscopy images of native and swelled starch granules of various starch types 
The microscopy images in Figure 5.3 demonstrate the physical changes in the various starch types as a they 
are heated for 30 min at 5% w/w in water. As expected, the particles grew larger in size with increasing 
heating temperatures. It is interesting to note that, with some of the starch types, swelling does not occur 
uniformly within all of the granules in the sample. In addition, some granules appeared to remain relatively 
unswelled before rapidly swelling, rather than swelling gradually between the various temperatures. This 
“popcorn popping” effect has also been observed by Cai et al. (2013). In the samples we tested, this effect 
is most strongly observed with potato and wheat starch. This effect has implications for obtaining a uniform 
size distribution which could be a requirement for a starch-based drug delivery system. 
Based on the optical microscopy results and the swelling power results in Section 5.4.1, we decided that 
potato was likely a poor option due to its rapid and extensive swelling. Further, with such similarities 
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between normal and waxy corn starch, and with amylose content likely not being important for our work, 
we could rule waxy corn starch out as a candidate. 
 
Figure 5.3: Brightfield microscopy images of pea, potato, wheat, waxy corn, and normal corn starch after 
swelling for 30 minutes at the indicated temperatures. Scale bars are 50 µm. 
5.4.3 SEM images of swelled normal corn, pea, and wheat starch 
At this point in evaluating the various starch types, the options we were still considering were normal corn, 
pea, and wheat starch. We swelled each of these starches and imaged them with SEM (Figure 5.4). Of 
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particular interest was the enlarged internal cavity that was observed in swelled normal corn and pea starch. 
Although such a structure has been previously described and imaged (Dhital et al., 2013; K C Huber & 
BeMiller, 2000; Sujka & Jamroz, 2013), our realization that the internal cavity increased size with partial 
swelling of the particles while the particles stayed mostly intact led to further investigating normal corn and 
pea starch for drug delivery. Normal corn starch appeared to swell more uniformly and to disintegrate less 
commonly, so it appeared to be a better choice for the application in mind compared to pea starch. 
 
Figure 5.4: SEM images of normal corn, pea, and wheat starch after swelling for 30 minutes at the indicated 




5.4.4 Particle size distributions of normal corn starch 
To evaluate the polydispersity of the starch samples, we measured particle size distributions of various 
starch normal corn (NC) starch samples (Figure 5.5). Data was obtained in 5˚C increments between 55˚C 
– 90˚C, however only selected data is shown in this figure for clarity (full data is provided in Appendix B). 
As expected, the particle size data confirms that larger particles were produced with increased swelling 
temperatures. The particle size distributions become wider with greater swelling. 
 
Figure 5.5: Particle size distributions of native normal corn (NC) starch and NC starch heated to 60˚C, 65˚C, 
70˚C, 80˚C, and 90˚C for 30 minutes.  
One method for quantifying polydispersity is to calculate the full width at half maximum (FWHM) for the 
particle size distributions. The FWHM is calculated by measuring the width of a distribution at a height 
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half of peak height. A lower FWHM indicates a more monodisperse distribution. The results of the FWHM 
calculations are given in Figure 5.6 and compared with the relative particle sizes. The relative particle is 
calculated by dividing each mean particle size by the mean particle size of native granules. If each particle 
within a sample swells the same amount proportionally, the FWHM should increase by that same amount 
proportionally. This trend is observed for particles with heating temperatures up to 70˚C. For temperatures 
above 70˚C, FWHM begins to decrease. This effect is likely due to one or both of two reasons: 1) the 
particles truly become more monodisperse as gradually all the particles achieve the “swelled” state and/or 
2) the laser analyzer has difficultly with picking up some of most highly swelled particles due to their highly 
translucent nature. Both effects would  narrow the size distribution. Our result is in agreement with results 
from Cai and colleagues who observed that most starch types they looked at had a range wherein individual 
granules start to swell and that the larger particles started swelling at lower temperature compared to smaller 
particles (Cai, Zhao, et al., 2014; Cai & Wei, 2013).  Li and Yeh also observed a weak correlation between 





Figure 5.6: Calculated full width at half maximum (FWHM) for particle size distribution data of native 
normal corn (NC) starch and NC starch heated to 55˚C, 60˚C, 65˚C, 70˚C, 75˚C, 80˚C, 85˚C, and 90˚C for 30 
minutes. The red dashed line demarcates samples for which the correlationbetween particle size and FHWM 
ends. 
5.4.5 Effect of centrifugal force on swelling power 
To roughly estimate the compressibility of partially swelled starch, we measured the swelling power at 
various centrifugal forces (Figure 5.7). We hypothesized that starch with little swelling would have very 
little compressibility and that highly swelled starch would be highly compressible. We also wanted to 
characterize the sensitivity of swelling power measurements to possible variations in centrifugal force, an 
important understanding for results that are heavily dependent on swelling power measurements. Our 
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results were as expected. Starch swelled at 70˚C had the greatest decrease in swelling power as the 
centrifugal force. This result suggests that more highly swelled starch is less rigid compared with less 
swelled starch or native starch. 
 
Figure 5.7: The effect of centrifugal force on the swelling power measurement of normal corn starch swelled 





5.4.6 Digestibility of native and swelled normal corn starch 
An important factor when creating an oral drug delivery system is how it degrades as it traverses the 
digestive tract. For a starch-based system, its digestibility is particularly important since it is normally 
digested somewhat easily. Using the standard method for determining digestibility (Englyst et al., 1992), 
we analyzed native normal corn starch, and then freeze dried native starch, NC65, and NC70 (Figure 5.8). 
The digestibility is greatly increased as indicated by the large increase in the amount of rapidly digestible 
starch and the large decrease in slowly digestible starch and resistant starch. The increase in digestibility is 
primarily due to the swelled starch making more starch molecules accessible to amylase – the enzyme 
which hydrolyses starch polymer. Increased accessibility to amylase increases the rate at which starch is 
broken down into sugars. The increase in digestibility from the swelling process does not help with creating 




Figure 5.8: Fraction of rapidly digestible starch (RDS), slowly digestible starch (SDS), and resistant starch 
(RS) for native normal corn (NC) starch, freeze-dried (FD) normal corn starch with heating at 20˚C, 65˚C, 
and 70˚C. Error bars represent SD of three technical replicates. Literature digestibility results (X. Chen et al., 
2018; H. Liu et al., 2014) for native normal corn starch are also included for comparison. 
5.4.7 Amylose content of native normal corn starch and solubilized starch after swelling 
To further characterize the partially swelled normal corn starch, we analyzed the amylose content of native 
normal corn starch and compared it with the supernatants of starch swelled at 65˚C and 70˚C (Figure 5.9). 
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The reason for analyzing the solubilized starch instead of the unsolubilized granules themselves is as 
follows: since the solubilized starch is a small amount (i.e. only 5% of the starch in NC70 granules become 
solubilized), any changes in the amylose content would be relatively small compared with directly 
measuring the solubilized fraction. The solubilized starch has over double the amylose content (>60% vs 
28%) compared to that of native corn starch, which indicates that it is the amylose that preferentially leaches 
out, in agreement with work by Shujun Wang et al. (2012). This result could have implications for 
understanding internal structural changes that occur as result of swelling. 
 
Figure 5.9: Amylose content of native normal corn starch, starch obtained from the supernatants when 





5.4.8 Inhibition of swelling as a result of cross-linking 
When the goal of a controlled release drug delivery system is to prevent or slow the release of the 
encapsulated drug, there are many ways in which this can be done. One method for slowing release is to 
reduce the mesh size of hydrogel that is between the encapsulated drug and external environment. Based 
on our previous work, partially swelled starch appears to behave somewhat like a conventional hydrogel. 
Hydrogels are typically defined as being cross-linked polymers with a high water content (70-99%) that 
don’t dissolve in water (Hoare & Kohane, 2008; J. Li & Mooney, 2016), and, while partially gelatinized 
starch isn’t chemically cross-linked, it could be considered as physically cross-linked. We hypothesized 
that chemical cross-linking of partially swelled starch particles would increase their stiffness and could 
lock-in any encapsulated drugs. Measuring stiffness on a microparticle requires specialized equipment, and 
so we measured inhibition of swelling as an alternate method for quantifying the effect of cross-linking. To 
the best of our knowledge, cross-linking of partially swelled starch has not been studied before. 
We first tested swelling inhibition with normal corn starch and pea starch that had been swelled at 65˚C; 
after cross-linking with STMP, we swelled the particles at a higher temperature of 90˚C (Figure 5.10). 
STMP was chosen as it commonly used for cross-linking starch (Fang et al., 2008; Gao et al., 2014; 
Wongsagonsup et al., 2014). We observed that cross-linked normal corn starch had a marked decrease in 
the swelling compared to the control. This was not the case for the cross-linked pea starch. We speculate 
that this difference could be the result either of poorer cross-linking extent for pea starch or, if equivalent 
cross-linking occurs, differences in starch polymer chain lengths which would impact the ability to prevent 
“slippage” between chains. Since gelatinization is a process where water imbibes the granules and results 




Figure 5.10: Swelling powers of normal corn (left) and pea (right) starch after initial swelling at 65˚C 
(orange) and then swelling at 90˚C after crosslinking with STMP (blue). The controls had the exact same heat 
treatment and all chemicals added for the cross-linking step other than the cross-linker (STMP) itself. 
To evaluate the effect of different amounts of cross-linker, we performed the same experiment with normal 
corn with low and high amounts of cross-linker, with initial swelling at 65˚C (Figure 5.11). As expected, 
the particles cross-linked with a high amount of STMP demonstrated a greater extent of swelling inhibition. 
A pseudo-replicate was also performed with initial swelling at 70˚C with similar results (Figure 5.12). These 
results indicate that STMP cross-linking could likely be used to increase the stiffness of the starch 




Figure 5.11: Swelling powers of normal corn starch after initial swelling at 65˚C (orange) and then swelling at 
90˚C after crosslinking with STMP (blue). The first control had the exact same heat treatment, but no 
chemicals added. The second control, “no STMP,” had the exact same heat treatment and all chemicals 
added for the cross-linking step other than the cross-linker (STMP) itself. The low and high treatments had 




Figure 5.12: Swelling powers of normal corn starch after initial swelling at 70˚C (orange) and then swelling at 
90˚C after crosslinking with STMP (blue). The first control had the exact same heat treatment, but no 
chemicals added. The second control, “no STMP,” had the exact same heat treatment and all chemicals 
added for the cross-linking step other than the cross-linker (STMP) itself. The low and high treatments had 
40 µg and 200 µg of STMP added during the cross-linking step, respectively. 
5.4.9 Zeta potential of partially swelled normal corn starch 
Zeta potential, a measure of the electrokinetic potential of a particle in solution, can provide insight on how 
drugs will interact with the particles. We measured this for native and swelled normal corn starch and found 
negative values for all, with native normal corn starch being the most negative (Figure 5.13). Our negative 
zeta potential result for native corn starch is in agreement with literature results where zeta potentials of 
roughly -39 mV for native rice starch (Wongsagonsup et al., 2005) and -40 mV for potato starch and -30 
mV for wheat starch (Marsh & Waight, 1982) were reported. Since zeta potential depends on the density 
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of the surface charge of the particles, we speculate that the greater diameter of the more swelled starch is a 
key factor that results in weaker zeta potentials. The negative charge of native granules is thought to be due 
to lipids with zwitterionic species which are negatively charged at ~pH 7 (Marsh & Waight, 1982). It should 
also be noted that when converting the electrophoretic mobility to zeta potential, it is assumed that the 
particles are spherical, and while the starch particles are somewhat spherical, they are not perfect spheres. 
Our results indicate that positively charge species will interact more favorably with the microparticles than 
negatively charged species and could leader to higher loading capability. 
 
Figure 5.13: Zeta potential of native normal corn starch (NC20), NC65, and NC70. N=3, error bars represent 
SD.  
5.4.10 Selective water uptake in native and swelled starch 
A method for rough characterization of a hydrogel’s pore sizes is to measure the amount of water that is 
selectively absorbed by the microparticles. The theory behind this method will be elaborated on further in 
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Chapter 6. We observed that all microparticle samples selectively uptake water. This is the result of hard 
sphere exclusion due to the relatively large size of BSA. We speculate that the decrease in water uptake for 
the NC100 could be the result of the polymer mesh size opening up, which allows for BSA to begin to enter 
the particles at this swelling extent. 
 
Figure 5.14: Selective water uptake by native and partially swelled normal corn starch when placed in a 
solution of 20 mg/mL BSA. 
 Conclusion 
This work presented in this chapter investigated various properties of various types of starch with the goal 
of establishing what sort of microparticles would make the best candidate for use in a drug delivery system. 
Our characterization of swelling powers and images of swelled starch revealed that that normal corn, pea, 
and wheat starch seemed like good options based on the ability to control swelling and rudimentary 
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morphological observations. SEM imaging revealed distinct internal cavities in partially swelled normal 
corn starch, which moved it to be the top contender for use in a drug delivery system.  The internal cavity 
seemed as though it could be used to encapsulate drugs. 
Particle size distributions indicated that the particles have a somewhat polydisperse size distribution, in 
agreement with our microscopy images. Through measuring the FWHM for the distributions, it appeared 
as though the particles first became more polydisperse as the particles swell moderately, which is likely the 
result of differences in the susceptibility of particles to swelling at a given swelling temperature. However, 
as we increased the swelling temperature (and thus created more swelled particles) the particles became 
more monodisperse, which we conjecture is the result of unswelled particles catching up to the already-
swelled particles. Swelling power, a useful measure of swelling extent, depends on the centrifugal pressure, 
with greater centrifugal force leading to smaller swelling pressures, the result of swelling reducing the 
mechanical rigidity of the microparticles. 
Digestibility, an important characteristic of a microparticle system intended for oral drug delivery, was 
determined to be much higher for partially swelled starch compared to that of native granules. Through 
analysis of the supernatant after swelling we determined, in agreement with work by others, that amylose 
preferentially leaches out. Cross-linking of partially swelled normal corn and pea starch was tested as 
method for increasing stiffness. By measuring the swelling power of cross-linked starch when heated, we 
determined that cross-linking normal corn starch increased its rigidity. The effect on pea starch was 
comparably negligible. 
An important characteristic of a microparticle that is intended to be loaded with drugs through adsorption 
is its surface charge. Negative zeta potentials, indicating negative surface charge, were measured for NC20, 
NC65, and NC70, with NC20 having the greatest negative charge. Lastly, selective absorption of water was 
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demonstrated with NC20 through to NC100; the mechanism for this selective absorption is hard sphere size 
exclusion of BSA due to BSA’s relatively large size. 
Chapter 6: Drug loading and release from starch microcapsules 
 Summary 
Native and swelled starch were loaded with methylene blue (MB) at various concentrations to establish 
loading abilities. A unique problem with characterizing loading of microparticles in solution through 
adsorption is knowing the interstitial and intraparticle volumes. We describe the combination of both of 
these volumes as the drug-accessible-water volume. To deal with this unknown, it is necessary to perform 
the right set of experiments to allow for it to be solved for. We conducted these experiments with methylene 
blue and observed adsorption for native normal corn starch, SMC65, and SMC70 of 3.61, 2.14, and 2.06 
mg/g and loading capacities of 3.81, 5.11, and 9.65 mg/g, respectively. We also conducted preliminary 
investigations into how the interstitial volume can be calculated, however more work beyond what is 
included here is required to calculate the value for each type of microparticle. Confocal laser scanning 
microscopy was also used to visualize the location of loaded RITC-dextran and FITC-BSA. 
 Introduction 
Characterizing the ability of a microparticles to uptake and release drugs is a key step in creating a 
microparticle-based drug delivery system. In most cases, a high drug loading capacity is desired. Some 
microparticle systems are loaded during microparticle formation and others are loaded after. If the particles 
are loaded during formation, depending on the particle characteristics, the particle loading efficiency may 
be close to 100%. Particles loaded during particle formation also generally have a very high loading 
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capacity. When particles are loaded after formation, the primary mechanism for loading is generally 
adsorption; however, some drug will also be loaded through absorption. If loaded through soaking in the 
drug solution, the limitation is the maximum adsorption of the polymer in solution. If loaded through freeze 
drying or spray drying, typically more drug can be loaded as most of the drug in the initial solution ends up 
dried onto or into the microparticles. 
In the work in this chapter, we attempt to characterize the loading characteristics of both native granules 
and swelled starch microcapsules (SMCs) from normal corn starch. 
6.2.1 Measuring interactions between drugs and hydrogels 
Since much of this chapter deals with characterizing the interactions between drugs and SMCs, a brief 
overview of drug-hydrogel interactions is provided. Although the term “drug” is used, this discussion 
applies to any solute. Characterizing adsorption of a drug with a hydrogel has been well studied. Adsorption 
is often used to measure the loading capacity of the hydrogel. The typical method for testing adsorption 
capacity is to place the hydrogel in a solution of the drug and measure how the drug concentration changes 
in the bulk solution. A simple mass balance can be done to calculate how much of the drug has been 
removed from the bulk. This amount of drug that is now in the hydrogel is used to calculate the loading 
capacity (LC) of the hydrogel, which is defined as 
LC ≝ mdrug/mgel 
where mdrug and mgel are the weights of the drug in the hydrogel and the weight of dry hydrogel polymer, 
respectively. Loading capacity is often interpreted to be the adsorption capacity of the hydrogel, but these 
two capacities are rarely equivalent. If there is a high water content of the hydrogel, it is likely that there is 
some drug in the hydrogel that is not actually adsorbed onto the hydrogel polymer. A better way to 
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characterize such a system is to calculate the equilibrium partition coefficient, k, which is defined by 
(Kotsmar et al., 2012) 
k ≝ Cgel/Cbulk 
where Cgel is the drug concentration in the hydrogel (per unit volume of the gel – both water and polymer) 
and Cbulk is the drug concentration of the external solution equilibrated with the gel. 
To account for the water in the hydrogel that contains the drug at a concentration of Cbulk, it is useful to use 
what Kotsmar et al. (2012) have called an enhancement factor, E, which is defined by 
E ≝ k/ϕw 
where ϕw is the water volume fraction of the hydrogel. 
If E = 1, there is either no interaction between the drug and the polymer or there is equal competing specific 
adsorption and size exclusion, which balance each other out. If E>1, then adsorption dominates. If E<1, 
then size exclusion dominates. If the drug size is large enough to completely prevent permeation of drug 
into the hydrogel, then E = 0. 
The factors that contribute to the enhancement factor, E, can be further defined, as described by Dursch et 
al (2014) when it is assumed that the free energies from different molecular combinations can be added 
together. This assumption is reasonable when the solution is dilute. With this assumption, the enhancement 
factor is defined as follows: 
E ≝ EexEelEspad 
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where Eex designates hard-sphere size exclusion, Eel designates nonspecific electrostatic interaction, and 
Espad designates specific solute adsorption on the polymer strands. While these authors differentiate between 
Eel and Espad, they can also be combined into Ead to represent total adsorption where Ead = EelEspad. 
 Materials and Methods 
6.3.1 Materials 
Normal corn (maize) starch was purchased from Sigma-Aldrich (S4126, Lot #: MKBT0621V) (Oakville, 
Canada). The apparent amylose content of the native starch was 27.8% as determined by the method of 
Williams et al. (1970). The moisture content was 14.3%, determined by the difference in weight as a fraction 
of the initial weight after drying for 16 hours at 100˚C. BSA, lysozyme, blue dextran, methylene blue, Fast 
Green FCF, FITC-BSA and RITC-dextran (MW: 70,000) were purchased from Sigma-Aldrich. 
6.3.2 Preparation of starch microcapsules (SMCs) through heating in water 
The starch microcapsules (SMCs) were prepared through a simple heat-treatment process. Native corn 
starch (0.7 g, dry basis), as received from the supplier, was added with Milli-Q water or PBS (14 mL) in a 
centrifuge tube at a concentration of 5% w/w (native, dried starch basis). To swell the starch, the centrifuge 
tube was placed in a water bath at the required heating temperature (65-75˚C) for 30 min with stirring of 
the water bath with a magnetic stirrer. The height of the water in water bath was carefully controlled to also 
cause gentle agitation of the centrifuge tube. After the starch was swelled, the starch mixture was cooled 
immediately to 20˚C by placing the centrifuge tube in a cold-water bath. For the MB adsorption experiment, 
the particles were freeze dried. For experiments where non-dried particles were required, the particles 
remained in solution and stored in the fridge until use. 
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6.3.3 Methylene blue adsorption 
Freeze dried starch samples (~80 mg) were added to 1.7 mL microcentrifuge tubes with methylene blue 
solution at various concentrations. After 16 hours (with rotation to ensure mixing), the tubes were 
centrifuged at 1000g for 1 min and the supernatant was analyzed using UV-vis spectroscopy at 660 nm. 
The supernatants were diluted as needed to ensure they were the linear range for concentration measurement 
and concentrations were determined from a standard curve. 
6.3.4 Model drug interactions with still-wet swelled starch 
SMCs were prepared as previously described in 15 mL centrifuge tubes but with PBS as the solvent. After 
decanting the supernatant, 10 mL of drug solution was added and allowed to equilibrate for ~4 hours. Model 
drug solutions included the following: BSA at 2 mg/mL, lysozyme at 300 µg/mL, methylene blue (MB) at 
100 µg/mL, blue dextran (BD) (2,000 kDa) at 1 mg/mL, Fast Green FCF at 200 µg/mL. Two measurements 
were taken to ensure the consistency of the results. The samples were then decanted, and 3 mL of PBS was 
added to act as the release media. Again, the mixture was allowed to equilibrate for ~4 hours and two 
measurements were taken. 
Concentrations for proteins (BSA and lysozyme) were measured through use of the BCA (bicinchoninic 
acid) total protein assay method with BSA protein standard at 2 mg/mL used as the calibration standard. 
The standard curve was fit to a 2nd order polynomial for the range from 0-2 mg/mL.  Concentrations for 
MB, BD, and fast green FCF were determined through UV-vis spectroscopy at their highest peaks of 660 





6.3.5 Fluorescent microscopy of starch 
Starch samples (native and SMC) were added to a solution of rhodamine B isothiocyanate conjugated with 
dextran (RITC-dextran) with a molecular weight of 70,000 g/mol at a concentration of 5 mg/mL and were 
left overnight at room temperature (~20˚C) for loading of the particles.  After loading, and about 15 min 
before the images were captured, 100 µL of the wet loaded particles were placed on filter paper using a 
pipette to wick away excess liquid. The particles were then removed from the filter paper and place on a 
microscope slide. A drop (~50 µL) of fluorescein isothiocyanate conjugated with BSA (FITC-BSA) 
solution at a concentration of 5 mg/mL was placed on the particles already on the microscopy slide and a 
coverslip was placed on top. Nail polish was used to seal between the edges of the coverslip and the slide 
to prevent evaporation and movement. Once the nail polish was dry (~5 min), the slide was placed on the 
microscope and images were taken using a confocal microscope (LSM 700, Carl Zeiss, North York, 
Canada) with illumination by the 488 nm laser using a 100x oil emersion objective. 
 Results and Discussion 
A goal of our work was to load the SMCs with drugs with the intent of being able to use them for drug 
delivery. Although beyond the scope of our current work, we imagined the particles could be used for 
controlled release for either oral or topical delivery of drugs. We did testing with several drug models: 
methylene blue, BSA, lysozyme, blue dextran, and fast green FCF. While we conducted various tests with 
the different molecules, we characterized the interaction of SMCs with methylene blue most thoroughly. 
We discuss this characterization first. 
A key to characterizing interactions of various model drugs with SMCs is to understand both the internal 
structure of the SMCs and how the particles are packed together in solution. 
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6.4.1 Characterizing adsorption of methylene blue to SMCs 
When microparticles are in solution, it is possible to measure the drug adsorption amount through 
calculating the change in concentration of the bulk volume. There is an added challenge in that the 
microparticles have drug solution between the individual microparticles, which we have called the 
interstitial volume However, one of two things is generally assumed depending on if the microparticles are 
already wet or not. If wet, it is assumed that the water already contained within the hydrogel does not dilute 
the drug loading solution. If dry, it is assumed that there is no interstitial volume between the microparticles 
(i.e. Eex = 1). In some cases, these assumptions may not affect the results significantly. But, depending on 
the hydrogel mesh size, the drug size, the water content of the hydrogel/microparticles, and the adsorption 
capacity of hydrogel, these assumptions can mischaracterize the nature of the interactions. 
Figure 6.1 demonstrates the various components of a system of microparticles and a drug solution in a test 
tube. In a conventional hydrogel system, the hydrogel takes up any volume that isn’t Vbulk, however in 
microparticle system Vinterstitial must be considered as well. We refer to the combination of Vmicroparticles and 
Vinterstitial as Vsediment: 
Vsediment = Vmicroparticles + Vinterstitial 
We refer to the paste-like volume at the bottom of the test tube as “sediment”. The sediment settles to the 
bottom over time due to the higher density of starch polymers compared to the density of water. We define 
Vstarch as the volume of the microparticles that contains starch polymer only or starch polymer and water; it 
is the volume of the particle that does not contain methylene blue (MB) in solution. It is possible for MB 
solution to reach Vintra though the non-homogenous Vstarch shell if there are pores or if there are areas with 




Figure 6.1: Schematic of microparticles in solution. 
When a drug solution is added to a solution of dry microparticles and allowed to equilibrate, we can measure 
the change in concentration of the bulk to characterize nature of the interaction between the drug and the 
microparticles. This data is shown in Figure 6.2 for various concentrations of MB and with NC20, NC65, 
and NC70. We refer to SMCs starch type (normal corn – NC), and the heating temperature. The loading 
concentration is measured prior to adding the MB solution to the dry microparticles. When a high 
concentration of MB is added to the microparticles (e.g. Figure 6.2b), some MB is adsorbed onto the 
microparticle polymer; however, as the particles become saturated with MB, most of the MB remains in 
solution. Conversely, when a low concentration of MB is added to the microparticles (e.g. Figure 6.2g), 
most of the MB is adsorbed onto the microparticles polymer leaving little in solution. This observation is 
true for NC20, NC65, and NC70 microparticles. Another way to look at the data is to compare how NC20, 
NC65, and NC70 differ in how the MB solution concentration changes for a given loading concentration. 
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In Figure 6.2a, we observe that the concentration is reduced the most by the NC20 sample and the least by 
the NC70 sample, with the NC65 result falling in between. This indicates that the native starch is best at 
adsorbing MB. 
 
Figure 6.2: Methylene blue loading concentrations (grey) and final equilibrium concentrations after loading 
(black) for various initial loading concentrations with the highest loading concentrations (a) at the top to the 
lowest (g) at the bottom. Each test was conducted with NC20, NC65, and NC70 starch microparticles. 
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A more standard method for characterizing the hydrogel-drug interaction is to calculate the partition 
coefficient, as explained in Section 6.2.1. The coefficient will be a function of the bulk MB concentration. 
Since the bulk concentration is already known (i.e. the final concentration in Figure 6.2), only the 
microparticle concentrations must be calculated. Calculating the microparticle concentration is challenging 
because we have an unknown variable: the amount of MB within the microparticles. If it is assumed that 
Eex = 1, then the reduction of MB in the bulk can only be attributed to adsorption. If Eex <1 and it is assumed 
that Eex = 1, the measurement for the amount of MB adsorbed will be lower than what it really is. The 
assumption that Eex=1, although probably not too incorrect for MB due to its small size, is not reasonable 
for larger molecules. 
There is going to be MB in the sediment that is not adsorbed onto starch due to Vinterstitial. Further, as long 
as Vintra is nonzero, there will also be MB that is in the microparticles, but not adsorbed. To account for the 
volume in the sediment that contains MB solution at a concentration of Cbulk (i.e. Vinterstitial + Vintra), an 
experiment must be done in the range of Cbulk where the starch polymer is fully saturated with MB. We call 
the volume in the sediment that has MB at a concentration of Cbulk the drug-accessible water (DAW): 
VDAW = Vinterstitial + Vintra 
By making an assumption for what VDAW is for each and using the data in Figure 6.2 we can plot Cbulk vs. 
qe to determine how high Cbulk needs to be for the starch to be saturated with MB, where qe (mg/g) is the 
amount of MB adsorbed at equilibrium per mass of starch. Once this concentration is known, we can do a 
mass balance for the amount of MB in the sediment between two experiments, one at a lower Cbulk, which 





mMB,sed,a = Cbulk,a·VDAW·mst,a + qe,a·mst,a 
mMB,sed,b = Cbulk,b·VDAW·mst,b + qe,b·mst,b 
In this case, VDAW is the specific volume (mL/g) per mass of starch. 









The result of calculating VDAW with the results in Figure 6.2a-c and averaging the two results is given in 
Figure 6.3. 
 




Although we now know VDAW, we still do not know how much of it consists of  Vinterstitial compared to Vintra. 
If the packing factor for the microparticles is known, then Vinterstitial can be calculated. The packing factor 
(PF) is defined as 
PF = Vmicroparticles/Vsediment 
The packing factor for native normal corn starch, or NC20, can be calculated geometrically based on the 
swelling power. However, assumptions for the porosity of the native granules and the density of starch 
polymer must be made. We measured the porosity of native normal corn starch using nitrogen gas 
adsorption to be about 0.01, however this method is not effective at measuring micropores (pores > 50 nm), 
which could be significant contributor to native granule porosity. We can however use the water content of 
native normal corn starch (~19 vol. %) as a rough estimate for porosity. Particle density was measured for 
corn starch as 1.5 g/mL for starch with a water content similar to ours by Marousis and Saravacous (1990), 
which is what we used. The resulting PF for native normal corn starch is calculated to be 0.505. 
By assuming that the packing factor for swelled starch is the same as that of native granules, the swelling 
power for swelled starch can be estimated as a function of swelling extent, which we can compare to our 
experimental results. The swelling extent (α) is the ratio of swelled particle radius to the native granule 
radius (see discussion in Section 4.4.3). Due to some uncertainty from our assumptions, we performed a 
sensitivity analysis to evaluate the effect of changes in our assumptions (Figure 6.4). Most notably, at high 
swelling extents, the only way for our experimental results for swelling power to match geometrically 
calculated swelling powers, the packing factor must increase beyond the initial ~0.5 of the native starch 
granules to about PF = 1. Increasing the packing factor to 1 only helps for particles with α<2. Beyond this 
swelling extent, packing factor must increase beyond 1 to match our experimental results. While PF>1 is 
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technically impossible for rigid particles, our particles are “squishy.” We speculate that, when centrifuged, 
the particles shrink through centrifugal pressure, effectively resulting in a PF>1. In other words, the original 
total particle volume prior to compression is greater than the total sediment volume when the particles are 
centrifuged. This speculation matched with results where we compared the effect of centrifugal force on 
swelling power (Section 5.4.5). We also observed decompression in NC70 of about 5% vol. in 20 minutes 
after centrifuging at 21,000g for 15 min, in agreement with our speculation. No decompression was 
observed for NC20 under the same conditions. This observation also indicates that the swelled particles 




Figure 6.4: Sensitivity analysis on calculated swelling powers from swelling extent (alpha). The initial porosity 
was changed while the other variables were held constant with PF = 0.5 and ri = 4.25 µm (a). Packing factor 
was changed while the other variables were held constant with ri = 4.25 µm and ϕi = 0.2 (b). The initial 
particle radius was changed while the other variables were held constant with PF = 0.5 and ϕi = 0.2 (c). 
Based on our comparison of theoretical calculations for swelling power from particle swelling extent and 
based on our PF calculation for native granule starch, for further calculations, we have assumed that PFNC20 
= 0.5, PFNC65= 0.75, and PFNC70 = 1. With these assumptions we are now able to calculate Vmicroparticles for 
our MB adsorption experiments, and thus, enhancement factors can be calculated (Figure 6.5). We observed 
that our calculated enhancement factors decrease at Cbulk increases, as expected. Of greater significance is 
 
115 
that native normal corn starch has a much higher enhancement factor compared to NC65, and higher still 
compared with NC70. We speculate the surface charge of native starch plays a large role in the adsorption 
capacity, as suggested by the more negative zeta potential (Section 5.3.10) of native starch compared with 
the partially swelled starch. 
 
Figure 6.5:  MB microparticle enhancement factors for NC20, NC65, and NC70 samples as a function of bulk 
MB concentration. 
Unfortunately, we are not aware of any results in literature that has measured the enhancement factor for 
starch with MB. However, we can compare our results with others’ by using the Langmuir adsorption 
model. The model, which assumes monolayer adsorption onto a flat plane, allows us to calculate qm and b. 
While the assumptions are likely not particularly valid for a hydrogel, the model is often used in literature 
for modeling of drug adsorption onto hydrogel microparticles, and as such allows for comparison to others’ 












where qe is the amount of MB adsorbed at equilibrium at a given Cbulk, qm is the maximum adsorption 
capacity, and b is the Langmuir adsorption constant. Using the fitted equations (Figure 6.6), we obtain the 
results in Table 6.1. 
 
Figure 6.6: MB adsorption results with linear fits for calculating Langmuir isotherm parameters. 
Although it is common to also model adsorption results with the Freundlich adsorption isotherm, based on 
work by others who looked at the adsorption of MB with cross-linked starch (Guo et al., 2013; X. F. Zhao 
et al., 2008), humic acid-functionalized starch (R. Chen et al., 2015), a porous graphene oxide/hydrogel 
nanocomposite (Pourjavadi et al., 2016), and Moroccan clay (El Mouzdahir et al., 2007) where they all 
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observed a much better fit with the Langmuir isotherm, we did not see the need for testing the Freundlich 
model with our results. 
Table 6.1: Langmuir isotherm model parameters based on the adsorption of methylene blue (MB) into starch 
microcapsules. 
Microparticle type qm (mg MB/g starch) b (L/g starch) 
NC20 3.61 0.080 
NC65 2.14 0.050 
NC70 2.06 0.014 
 
R. Chen et al. (2015) studied the effect of starch grafted with humic acid on its ability to adsorb MB and 
measured adsorption capacity (qe,max) of ~7 mg/g at neutral pH (compared to ~90 mg/mg for starch-humic 
acid). Unfortunately, they did not report the type of starch they used. Our result of qm = 3.61 mg/g for native 
corn starch is comparable. Junlapong et al. (2020) reported an adsorption capacity of ~2000 mg/g with a 
hydrogel based on cassava starch and acrylamide, however this result seems unlikely as most reports of 
MB adsorption onto activated carbon are less than 500 mg/g. 
A final comparison of MB adsorption to loading capacity illustrates the difference between the two 
characterization methods. The maximum loading capacities are given in Table 6.2. Loading capacity 
increases as swelling increases due to the higher volume of the microparticles, which led to a higher drug-





Table 6.2: Loading capacities of methylene blue (MB) into normal corn microcapsules. 





6.4.2 Analysis of drug-accessible water through drug loading and release 
From our analysis in the previous section of loading of native and swelled starch, we had a good estimation 
of the drug-accessible water (DAW) for a starch-MB system which helped with charactering the absorbed 
MB amount. This DAW only applies to that system. Use of a different drug or adding another solvent could 
give different results. Our intent was to characterize the true interstitial volume (Vinterstitial) rather than use 
our estimate based on geometrical calculation as we did in the previous section. We quantified how various 
model drug solutions would be diluted by adding the solution to the already “wet” microparticles (i.e. the 
sediment) whereby the drugs become loaded into the microparticles. After loading, we then decanted the 
supernatant – leaving the drug-loaded microparticles in sediment – and then added drug-free solution to the 
sediment to evaluate how much loading solution was left in the sediment based on dilution. If one of our 
model drugs was both a) large enough that through size exclusion no drug would enter the microparticles 
(i.e. Eex = 0) and b) non-adsorbent towards the outside of the microparticles (or at least this adsorption was 
negligible), Vinterstitial could be calculated. The amount of Vinterstitial for each of our model drugs, with making 
both those assumptions, is shown in Figure 6.7. Our results are somewhat inconclusive, but some 
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observations can be made. Unlike with the previous loading experiments, these particles were swelled in 
PBS instead of in water. 
Since BSA and blue dextran are the largest two molecules, we would expect one of these to give the lowest 
values of the specific volume. The lower the specific volume, the more size exclusion dominates over 
adsorption. However, while the results for BSA are all positive values and reasonable, some of our results 
from blue dextran were negative, which cannot be the case as there is no mechanism to cause the blue 
dextran concentration to increase. 
Also of interest is that for the BSA results, the specific volume increased as the particles became more 
swelled. This increase could be the result of greater interstitial volume simply due to granule swelling; 
however, for the interstitial volume to be the main reason for the increased specific volume, the packing 
factor needs to stay close to the packing factor of the unswelled granules. However, an unchanging packing 
factor seems unlikely due to the high compressibility of the particles. What is more likely is that the increase 
could be the result of the mesh size of the swelled starch increasing enough to let BSA enter the swelled 
particles, which effectively allows for greater reduction in Cbulk,BSA, which results in a higher specific 
volume. In other words, the native starch might not be permeable to BSA, but upon swelling the increased 
mesh size allows for diffusion of BSA into the particles. 
One final observation is that with methylene blue, we observed an opposite trend compared to our similar 
experiments in pure water: greater swelling of PBS-swelled particles led to higher adsorption of MB. We 





Figure 6.7: Vinterstitial results for loading and release of BSA, lysozyme, methylene blue, blue dextran, and fast 
green FCF. N=2. Error bars represent SD. 
6.4.3 Confocal laser scanning microscopy of microparticles loaded with model drugs 
Confocal laser scanning microscopy can be a useful tool for observing the interior of microparticles. The 
ability to only observe a cross-section of a sample that contains a fluorescent dye can allow the observer to 
see exactly where that dye is spatially. The images are particularly useful with a rather nonhomogeneous 
system like we have with the SMCs. The result of loading our particles with RITC-dextran (70kDA) 
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followed by brief washing with a solution of FITC-BSA and then immediate observation is shown in Figure 
6.8 The initial loading step with RITC-dextran allowed for equilibrium loading of RITC-dextran (stokes 
radius: 5.8 nm). The washing with FITC-BSA washed out any free RITC-dextran. We observe that with 
NC20, both RITC-dextran and FITC-BSA appear to adsorb onto the outer edge of the granules. For NC70, 
we notice that while most particles that likely previously contained RITC-dextran solution are washed out 
by the FITC-BSA, there are three particles (white arrows in Figure 6.8) that easily retain the RITC-dextran 
solution, indicating that the particles have walls that are fully intact and, at a minimum, prevent quick 
leakage of the encapsulated solution. 
 
Figure 6.8: Confocal laser scanning microscopy of NC20 and NC70 microparticles. Each set (NC20 and 
NC70) of images were all taken moments apart with images (a) and (d) depicting excitation/emission of both 
FITC-BSA and 70kDa RITC-dextran, with images (b) and (e) depicting excitation/emission of only RITC-




Our work in this chapter demonstrated a novel method for characterizing adsorption of a solute onto and 
into microparticles in a way that accounts for the interstitial volume and the volume inside the 
microparticles themselves. This method is helpful for isolating the amount of drug that is truly adsorbed on 
the microparticles and not just encapsulated simply due absorbed solution at the bulk concentration. Using 
this method, we calculated the volume that methylene blue (MB) can access within the starch sediment, 
and we observed that greater swelling led to a higher volume of this drug-accessible water. 
The relationship between swelling extent and swelling power can be calculated geometrically after using 
some assumption and estimates for some variables. Our comparison with our experimental results revealed 
that it seems likely that the packing factor increases from about 0.5 for native normal corn starch granules 
to roughly 1 for NC70. For particles with greater swelling than NC70, for our results to match the theoretical 
swelling powers, the packing factor must be greater than one. We interpret this result to mean that our 
particles are greatly compressed during centrifugation, resulting in the total sediment volume being smaller 
than the initial total microparticle volume prior to centrifugation. Estimations of the packing factor for each 
type of microparticle made it possible to calculate the concentration of MB for the microparticles 
themselves. These concentrations made it possible to calculate the enhancement factor for the MB-
microparticle system for NC20, NC65, and NC70 as a function of bulk MB concentration. As expected, 
NC20 has the highest enhancement factor. Through Langmuir isotherm modeling, we established that 
native normal corn starch has a higher adsorption capacity compared with swelled SMCs. However, due to 
the higher water content and higher swelled volume, the loading capacity is technically higher for NC70 
compared with NC20. 
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In order to evaluate the capacity of microparticles for drug delivery, it is useful to characterize the 
interaction between several model drugs with the microparticles. We conducted a set of experiments where 
we added solutions of five different model drugs to already-wet starch. Our hope was also that one of our 
drugs would be large enough that hard-sphere size exclusion would dominate, which would allow for 
calculation of the interstitial volume for each microparticles type. The starch-BSA interaction appears to be 
dominated by size exclusion. The volume in the sediment that can be diluted by a BSA solution increases 
as swelling extent increases. We speculate that this increased volume is the result of the increased mesh 
size from swelling, which allows entry of the relatively large-sized BSA. 
Confocal laser scanning microscopy is a useful tool for observing the interaction between fluorescent dyes 
and microparticles. Through loading with 70 kDa RITC-dextran followed by washing with FITC-BSA, we 
observed differences in how particular microparticles interact with the dyes. Some particles clearly 
demonstrated their capacity for encapsulating dye that, at a minimum, does not leak out rapidly. 
Chapter 7: Conclusions and Recommendations 
 Contributions 
In our work, we thoroughly studied the swelling process of various starch types, with a focus on normal 
corn starch, in pursuit of using partially swelled starch for use in controlled release drug delivery. We refer 
to the partially swelled starch as starch microcapsules (SMCs). 
First, we reported on application of helium ion microscopy (HIM) for imaging of native corn starch 
granules. We used a novel sectioning technique to allow access to the internal structure for observation with 
minor disturbance. We determined that HIM is a useful technique for probing starch structure and that it 
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can resolve features smaller than 10 nm in size. New mesh-like features not previously reported on with 
AFM or SEM were observed. A comparison to SEM images revealed the significant improvement in 
imaging resolution. HIM offers a new way to better understand the internal structure of starch granules. 
Next, we studied the starch gelatinization process for normal corn starch, with an emphasis on the 
intermediate steps before full gelatinization. We demonstrated that swelling extent can be easily controlled 
through modulation of swelling temperatures and swelling times. As a result of swelling extent being 
closely correlated with particle size and solubility, these properties may also be controlled. The ability to 
tune the particles could be useful for applications in drug delivery. We characterized SMCs to understand 
their change in morphology as a result of swelling. The internal cavity present in native normal was shown 
to increase in size as the particles increase in size. We observed the structural changes in the swelling 
process through use of SEM, HIM, and CSLM imaging. Due to the geometry of the SMCs and their internal 
cavities, only a small change in particle size is required to cause a large change in the internal cavity size. 
We modeled this change mathematically and fit this model to our experimental data, which matched very 
closely. 
Before proceeding further with investigation on the ability of partially swelled starch for use in drug 
delivery, we evaluated a few starch types to determine the best candidate for the task. Due to controllability 
uniformity of the internal cavity, we choose normal corn starch as the best option. We conducted extensive 
characterization of SMCs made from normal corn starch to help understand various aspects of its 
polydispersity and chemical and physical properties. We compared the changes in these properties with 
native starch granules. With characterizing swelling extent being vital to our work, we concluded that 
centrifugal force influences swelling power measurement and that the SMC are somewhat compressible. 
When microparticles are to be used orally, their degradation in the gastrointestinal tract is important for 
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how drugs are released. To understand how SMCs could react to this environment, we measured the 
digestibility for SMCs and established that the swelling process greatly increased the digestibility of the 
particles. Cross-linking could provide a method for either reducing digestibility or slowing the diffusion of 
drugs out of the microparticles. We cross-linked starch and used measurement of swelling inhibition to 
determine that the rigidity of normal corn SMCs starch increased. When drugs are to be loaded through 
adsorption, surface charge is important, and, using measurement of zeta potential, we determined the 
surface charge of normal corn starch to be negative, with greater swelling leading to less negative surface 
charge. Selective absorption of water in a solution of BSA demonstrated that size exclusion plays a factor, 
which could have implications for the loading capacities of SMCs. 
 In the last section of our work, we quantified the adsorption capacity of normal corn SMCs with methylene 
blue (MB). Work in literature has quantified adsorption of MB into starch microparticles but has failed to 
account for possible size exclusion. In other cases, loading capacity is determined but fails to account for 
the interstitial water between the particles. We quantified the interaction between MB and SMCs with 
taking these factors into consideration. We determined that while adsorption onto native granules was the 
highest, swelled SMCs allowed for the highest loading capacities. To determine the interstitial volume, a 
solute that exhibits complete size exclusion and no adsorption must be used. We used five different model 
drugs to see if any would display such behaviour. While our results were somewhat inconclusive for 
determining the interstitial volume, we were able to make other observations. The trend of highest 
adsorption of MB in native granules compared with SMCs in water was flipped when conducting the same 
experiment with SMCs in PBS. Finally, with use of confocal laser scanning microscopy, we observed the 
interaction between particles loaded with RITC-dextran followed by quick rinsing with FITC-BSA and 
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were able to conclude that some particles demonstrate the capacity for at least brief encapsulation of RITC-
dextran. 
 Recommendations 
To better evaluate the loading and release capability of SMCs, further testing should be done with a wider 
variety of large solute to determine the interstitial volume with confidence. Some of our later experiments 
revealed that solubilized starch affected accuracy of determining solute concentrations. While this effect 
can be mitigated through use of controls that can be used to subtract the effect of solubilized starch, a better 
solution could be to wash the microcapsules prior to conducting loading and release experiments to remove 
all solubilized starch. 
A potential limitation for applicability of SMCs is their wide size distribution which could lead to higher 
variability in characteristics. Further experiments should be conducted to determine what the effect of 
particle size is on drug loading and release. If the effect is significant, it could be useful for develop a 
method for sorting the SMCs by size. It is likely that a microfluidic process could be used to take advantage 
of differences in particles sizes or densities. 
Based on our results, drug loading and release occurs relatively quickly. Quick equilibrium is typically not 
ideal for a system where the idea is to have the drugs be released over a long period of time. It could be 
very useful to develop a method for locking in the drug after having loaded them into the particles. We 
suggest that cross-linking of the outer shell of normal corn SMCs could provide this ability. Another option 
could involve coating the microparticles with a different polymer. When the goal of a drug delivery system 
is to target the intestine or the colon, a pH-controlled release is generally useful. Adding a pH-responsive 
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polymer could allow such controlled release, with the SMCs contributing by allowing for high 
encapsulation with its large internal cavity. 
One way to tune the properties of SMCs is to control where gelatinization occurs within the particle as a 
result of heating. We speculate that it might be possible to only swell the outermost part of the starch granule 
by rapidly passing single granules through a short heated section of tube. The rate would need be fast 
enough that only the outer portion of the starch granule is exposed to the high-enough heat to cause 
gelatinization (e.g. 70-100˚C), but that the interior remains cool due to a thermal gradient. On this scale, an 
individual particle likely reaches thermal equilibrium in less than a second, so the process would need to 
be very quick. A microfluid system with a very short heated section followed by immediate cooling would 
likely work. 
It could be useful to allow control of each particle to allow for reaction with a specific amount of reagent 
or to allow for loading of a precise amount of drug. We speculate that this control could be achieved using 
a water-in-oil emulsion where a single particle in an aqueous solution would be isolated into an oleic carrier 
phase. It is conceivable that a system could be set up that adds a variable amount of the reagent based on 
the previously measured size of the particular microparticle. A small microneedle would be needed to inject 
reagents or drugs; however, these chemicals could probably be added either right before encapsulation in 
the oleic phase or after. 
Partially swelled starch could also be investigated for use in a low porosity scaffold or foam whereby the 
starch microparticles would act as the template for the void spaces. Due to the apparent “squishy” nature 
of the particles, the contact area between particles is relatively high compared to non-compressible spheres. 
A polymer would be added to fill the intraparticle space that would then be cross-linked. After cross-linking, 
a solution of amylase would be used to selectively hydrolyze the amylose and amylopectin, leaving the 
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cross-linked polymer as the scaffold. Since swelled starch microparticles are roughly the same size as cells, 
this could work well for system where a single cell is required in each void space.
 129 
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Appendix A – Supplementary Information for Chapter 3 
 
Figure A.1: HIM image of a sectioned native Hylon VII starch granule. The inset in the black box is an image 
of the granule at lower magnification where the white box demarcates the section of the granule that is 




Figure A.2: HIM image of a sectioned native potato starch granule. The inset in the black box is an image of 
the granule at lower magnification where the white box demarcates the section of the granule that is imaged 




Figure A.3: HIM image of a sectioned native wheat starch granule. The inset in the black box is an image of 
the granule at lower magnification where the white box demarcates the section of the granule that is imaged 
at high magnification. 
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Appendix B – Supplementary Information for Chapter 5 
 
Figure A.4: Particle size distributions for native normal corn starch and swelled starch with heating for 30 
minutes at 55, 60, 65, 70, 75, 80, 85, and 90˚C. Data has not been normalized with respect to peak distribution 
height. For this data, peak height is meaningless and is simply the result of the bins used for the assigning the 
individual particles size data. 
 
 
